The binding of pyridoxal phosphate analogs to glutamic oxaloacetic transaminase by Furbish, Francis Scott
Retrospective Theses and Dissertations Iowa State University Capstones, Theses andDissertations
1969
The binding of pyridoxal phosphate analogs to
glutamic oxaloacetic transaminase
Francis Scott Furbish
Iowa State University
Follow this and additional works at: https://lib.dr.iastate.edu/rtd
Part of the Biochemistry Commons
This Dissertation is brought to you for free and open access by the Iowa State University Capstones, Theses and Dissertations at Iowa State University
Digital Repository. It has been accepted for inclusion in Retrospective Theses and Dissertations by an authorized administrator of Iowa State University
Digital Repository. For more information, please contact digirep@iastate.edu.
Recommended Citation
Furbish, Francis Scott, "The binding of pyridoxal phosphate analogs to glutamic oxaloacetic transaminase " (1969). Retrospective Theses
and Dissertations. 3575.
https://lib.dr.iastate.edu/rtd/3575
This disseitafioa has been 
mîcroËhned exactly as received 69-20,641 
FURBISH, Francis Scott, 1940-
THE BINDING OF PYRIDOXAL PHOSPHATE ANALOGS 
TO GLUTAMIC OXALOACETIC TRANSAMINASE. 
Iowa State University, Ph.D., 1969 
Biochemistry 
University Microfilms. Inc.. Ann Arbor. Michigan 
THE BINDING OF PYRIDOXAL PHOSPHATE ANALOGS 
TO GLUTAMIC OXALOACETIC TRANSAMINASE 
Francis Scott Furbish 
A Dissertation Submitted to the 
Graduate Faculty in Partial Fulfillment of 
The Requirements for the Degree of 
DOCTOR OF PHILOSOPHY 
Major Subject: Biochemistry 
D 
Iowa State University 
Ames, Iowa 
1969 
Approved: 
In Charge of Major Wôrk 
:aa of Major Department He d"
Signature was redacted for privacy.
Signature was redacted for privacy.
Signature was redacted for privacy.
il 
TABLE OF CONTENTS 
Page 
INTRODUCTION 1 
REVIEW OF PERTINENT LITERATURE 5 
EXPERIMENTAL 21 
RESULTS 27 
DISCUSSION 86 
SUMMARY OF CONCLUSIONS 102 
LITERATURE CITED 104 
ACKNOWLEDGMENTS 111 
1 
INTRODUCTION 
The enzyme» glutamic oxaloacetic transaminase (L-aspartate: 
2-oxoglutarate aminotransferase, EC 2.6.1.1), has been intensively 
studied by a large number of investigators. Interest in this particular 
enzyme was stimulated by a number of factors: 1) the important posi­
tion occupied by this transaminase in intermediary metabolism, 2) 
the experimental accessibility and comparatively easy preparation in 
contrast to other transaminases, 3) its role as a mechanistic prototype 
of group-transferring enzymes which operate through binary complexes, 
and 4) increased awareness of the role of the protein-bound 
cofactor, pyridoxal-5'-phosphate. In addition, the clinical im­
portance of this enzyme has recently been stressed by workers in the 
medical areas. 
Glutamic oxaloacetic transaminase (GOT) catalyzes the two half 
reactions shown below with the coenzyme serving as an amino group 
NHo O 
I I i 
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GOT-PLP ^ ^ GOT-PMP 
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carrier. By reacting with amino acid^, the aldehyde form of the 
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PMP-enzyme then reacts with keto acid^ to form amino acid^ thereby re­
producing the PLP-enzyme. Since two forms of the enzyme are involved and 
the overall enzymic reaction is the sum of the two half reactions, GOT ex­
hibits the kinetic characteristics of the Ping-Pong Bi Bi mechanism. The 
two amino acid substrates (L-glutamate and L-aspartate) are both focal 
points for intermediary nitrogen metabolism, and the two keto acids (a-
ketoglutarate and oxaloacetate) are both components of the tricarboxylic 
acid cycle. All four metabolites are maintained in balance by this enzyme. 
Although purified GOT preparations were not available until about 
1950, the general features of the reaction mechanism were recognized 
some time before on the basis of the coenzyme's properties. Moreover, 
these features were confirmed in nonenzymic model systems simplifying 
mechanistic matters somewhat for the enzymologists. Nevertheless, 
model system studies could not portray the tremendous catalytic ability 
of the enzyme since the enzyme increases the rates of the slow steps 
in the reaction by factors of 10^—10^. Such studies did point out, 
however, the possible roles of functional groups presumed to be present 
at the active site of GOT. In particular, a group capable of general 
acid-base catalysis was predicted to be in the vicinity of the active 
center; it is now known that at least two such groups are available 
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It is apparent from its participation in enzymic transamination that PLP 
is bound to the protein in a manner as to give it a precise alignment 
with the enzyme-bound substrate and the catalyticaTly functional groups 
of the protein. 
The nature of this coenzyme binding is the subject of the present 
investigation. Certain analogs of PLP were utilized in connection 
with the resolved enzyme (apoGOT) to ascertain the role of some of the 
functional groups of the cofactor. This approach has been taken before 
(see under Coenzyme Binding, Review of Pertinent Literature) and has 
yielded useful information. In particular, the binding of the 
5'-phosphate was examined by use of analogs with varied substituents 
in the 5'-position. The analogs used for this study consisted of 
carboxymethyl-deoxypyridoxal (III), deoxypyridoxalyl phosphonic acid (IV), 
CHO CHO 
CHgCHgCOgH CH2PO3H2 
111 IV 
the methyl phosphonic acid of pyridoxal phosphate (V), the cyanoethyl 
ester of pyridoxal phosphate (VI). pyridoxal (VII), and deoxypyridoxal 
(VIII). 
CHO 
H2O PO2H 
CHO 
V 
H CH. H3C-w 
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N 
OC2H4CN 
4 
HO 
HO 
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CH 3 
Also investigated was the effect of substituants on the pyridine 
nitrogen. The two analogs, N-methyl-pyridoxal phosphate (IX) and 
pyridoxal phosphate-N-oxide (X), were used for this study. 
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H 
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+ 
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CH. 
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REVIEW OF PERTINENT LITERATURE 
The early history of enzymic transamination and the discovery of 
coenzyme functions of pyridoxal phosphate have recently been reviewed 
by Braunstein (1960) and by Guirard and Snell (1964). Since these 
reviews and that of Meister (1965) have discussed the role of GOT in 
amino acid metabolism, emphasis here will be placed on papers concerned 
with the isolation and structure of the GOT molecule, its mechanism, 
and the binding of coenzyme. 
Isolation 
Simple homogenates or crude fractions were utilized in early work 
with GOT as the enzyme proved difficult to purify; furthermore, the 
extensive ammonium sulfate precipitations usually led to resolution 
(O'Kane and Gunsalus, 1947). A highly purified preparation was finally 
obtained from pig heart by Jenkins et (1959b) who employed an 
impressively effective heat treatment in the presence of maleate followed 
by ammonium sulfate fractionation and chromatography on hydroxylapatite. 
Later preparations sometimes included precipitation by cold acetone 
(Jenkins, 1960). Banks and Vernon (1961) obtained a preparation about 
95% pure by use of calcium phosphate gel and ammonium sulfate and 
ethanol fractionations; however, the enzyme was resolved during the 
purification and the yields were quite low. The Jenkins procedure was 
used until Turano and coworkers (1964) demonstrated that one thiol group 
(out of a total of six present in the molecule) was converted by maleate 
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into the corresponding S-(a,6-dicarboxyethyl) derivative; this particular 
thiol group was shown to be located at or near the active site by 
Ballio and coworkers (1966) since the S-(a,&-dicarboxyethyl)cysteine 
residue prevented the resolution of the enzyme under mild conditions. 
In order to avoid this structural modification, the enzyme is now 
prepared by using glutarate or succinate for protection during the 
heat treatment. While GOT has been prepared from several sources, most 
studies have concentrated on the pig heart enzyme. 
The discovery of the existence of several forms of GOT further 
complicated the effort to isolate a homogeneous preparation. A review 
of the early studies of GOT isozymes has been compiled by Wilkinson (1965, 
pp. 95-103). The GOT from pig heart has been the subject of intensive in­
vestigation by several workers (Nisselbaum and Bodansky, 1964, 1966; 
Wada and Morino, 1964) which has demonstrated the occurrence of two 
different enzymes, one associated with the cytoplasm and the other 
with mitochondria. The mitochondrial isozyme, which is cationic, is 
largely destroyed by the heat treatment, while the anionic cytoplasmic 
isozyme readily survives this step. Martinez-Carrion and others (1967) 
have shown that each of the isozymes contains at least three subforms 
and have employed a carboxynœthyl—sephadex column procedure for the 
isolation of the main subforms of cytoplasmic GOT. These subforms were 
found to differ in their specific activity and spectral properties. 
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Structure 
With the isolation of large amounts of highly purified GOT from 
pig heart, studies began on the chemical features of the enzyme. In 
the period 1960 to 1966 much work on the protein chemistry of GOT 
such as amino acid composition (Turano, et 1963), the role of 
sulfhydryl groups (Polyanovsky and Torchinsky, 1962; Turano, et al., 
1963), optical rotatary dispersion (Fasella and Hamnies, 1965), the 
sequence of amino acids at the PLP binding site (Hughes, et al., 
1962; Polyanovsky and Keil, 1963) and quaternary structure 
(Polyanovsky and Makarova, 1966) was performed. However, these studies 
utilized preparations containing various mixtures of the GOT isozymes 
and their subforms. Martinez-Carrion, et aj^. (1967) repeated most of 
the basic structural work on purified preparations of the three major 
subforms (a, g, and y) of cytoplasmic GOT. Their paper provides a 
convenient summary of present knowledge in this area and, unless other­
wise noted, is the source for the following. 
Primary structure 
The content of individual amino acids is within the limits generally 
encountered in proteins except for a relatively low content of serine 
and a relatively high content of proline, arginine and tryptophan. Of 
interest is the fact that GOT contains twenty lysyl residues and four 
sulfhydryl groups (one of which is buried in the protein and is exposed 
in 8 M urea) per mole of PLP. Although no significant difference 
was found in the amino acid composition of the various subforms, it 
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cannot be excluded that the subforms may differ by a few residues 
because of the relatively large molecular weight (47,000 3,000 g 
per mole of coenzyme) of the enzyme. Similarity of primary structure 
between the subforms was also demonstrated by fingerprints of tryptic 
digestions with the same 38 peptides appearing on the electrophoretogram 
of each subform. 
Hughes, et (1962) provided the means to determine the amino 
acid sequence at the PLP binding site by reducing the lysyl residue-PLP 
Schiff base with sodium borohydride, thereby stably binding the coenzyme 
to the apoenzyme. Polyanovsky and Keil (1963) have reported this 
sequence to be -lys-pyridoxyllys-ser-asp (or aspNHgj-phe-. The 
presence of two adjacent lysyl residues (one with coenzyme attached) 
has been demonstrated in another PLP enzyme, glutamic-pyruvic transaminase 
(EC 2.6.1.2) (Pfleiderer, et aj.., 1968). 
Secondary and tertiary structure 
Information relating to this area is particularly scanty and what 
exists is rather nebulous. Turano, et (1963) determined that GOT 
is composed of two polypeptide chains with no detectable differences 
between them. Optical rotatory dispersion (ORD) measurements by 
Fasella and Hammes (1965) in the ultraviolet region indicate that the 
enzyme has a considerable amount of ordered structure (i.e. helical 
content). No difference greater than experimental error was found in the 
UV ORD between the various subforms by Martinez-Carrion, et al_. (1967). 
These authors also investigated the behavior of the transaminase subforms 
in concentrated urea. It had previously been determined that in the 
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presence of 8 M urea GOT rapidly and reversibly loses activity to about 
25% of the original activity and then decays more slowly to the vanish­
ing point. The rate of activity loss cannot be described by a simple 
equation (Fasella and Hammes, 1964) and changes in spectrum, optical 
rotation, and fluorescence suggest that an extensive conformation 
change occurs with the slow activity loss step. When repeated with 
the separate subforms, Martinez-Carrion and coworkers found that the 
rate of the slow conformational change was faster for the a subform than -
for the B. While these authors have intrepreted the results to show 
that the a subform has a less rigid or compact structure than the 6, 
such a difference is not demonstrated by ORD. It is interesting to 
note that after extensive perturbation by exposure to concentrated 
urea, the subforms still retain their electrophoretic individuality. 
The authors suggest that the individuality of the subforms arises 
from a difference in the secondary and tertiary structure which occurs 
in that part of the protein molecule which retains some ordered 
structure even in concentrated urea. 
Quaternary structure 
On the basis of polarization of fluorescence techniques, Polyanovsky 
and Ivanov (1964) suggested that GOT dissociates into subunits upon 
dilution. Recent work by Banks et (1968c) has shown such dissociation 
to occur only at a very low level of concentration (10 to 1 mpM) and that 
both the dimer and the monomer units have the same specific activity. 
The dimeric molecule does dissociate into two monomers at extreme pH 
values (Polyanovsky and Makarova, 1966) and upon succinylation of the 
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protein (Polyanovsky, 1965). Dissociation into subunits does not 
occur under the conditions normally employed in GOT studies. 
Mechanism 
The establishment of the generally accepted mechanism of 
pyridoxal phosphate-catalyzed transamination (sometimes called the 
PLP-PMP shuttle mechanism) as proposed by Braunstein and Shemyakin 
(1953) and independently by Metzler et (1954) has been extensively 
reviewed (Meister, 1962; Braunstein, 1960, 1964; Guirard and Snell, 1964). 
Hence, the general mechanism for GOT is summarized in Figure 1 and is 
only briefly described here. An imine is formed between the coenzyme 
and the enzyme-bound substrate amino acid by a transaldimination 
reaction (reactions 1 and 2 in Figure 1) which ruptures the aldimine 
linkage between a lysyl e-amino group of the protein and the 4' 
carbon of the coenzyme. The transaldimination is thought to proceed 
via an intermediate with the 4'-carbon of the coenzyme in a tetrahedral 
configuration (referred to as a tetrahedral addition intermediate). 
Tautomerization of the enzyme-amino acid Schiff base—the rate limiting 
step—produces an intermediary enzyme-keto acid Schiff base, a ketimine 
(reactions 3 and 4 in Figure 1). It is reasonable to suppose that 
this conversion proceeds through a resonance-stabilized carbanion after 
loss of a proton from the enzyme-amino acid Schiff base. Hydrolysis 
of the ketimine yields a keto acid-enzyme complex with the coenzyme in 
the aminic form (reaction 5 in Figure 1). Release of the keto acid 
completes the half reaction. 
Figure 1. Binary mechanism of pyridoxal phosphate function in GOT 
(Guirard and Snell, 1964) 
Reactions: 1,2. Transaldimination 
3,4. Tautomerization 
5. Hydrolysis 
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The detailed mechanism of the reaction catalyzed by GOT with 
normal substrates has been investigated essentially by three approaches: 
steady state kinetics, fast reaction kinetics, and equilibrium studies 
of the reaction between high concentrations of the enzyme and the 
substrates. 
Steady state kinetics 
Steady state kinetics of GOT has been studied by several investi­
gators (Henson and Cleland, 1964; Wada and Mori no, 1964; Nisselbaum 
and Bodansky, 1964, 1966; Velick and Vavra, 1962). While some numerical" 
values of kinetic constants varied considerably, all the results were 
consistent with the binary mechanism. Velick and Vavra (1962) also 
included product and substrate inhibition (as did Henson and Cleland, 
1964) and pH dependence studies which showed that only the non-
protonated aldimine GOT reacts with amino acids (the pK is 6.2 for the 
protonation). These authors also demonstrated competitive inhibition 
of the amino acid substrates by keto acids. Banks et (1968a) have 
reported on the isotope effects induced by replacing the hydrogen atom 
bound to the substrate's a-carbon with deuterium; they conclude that 
the rate limiting step involves loss of the a-hydrogen from the amino 
acid. These authors take the view that a carbanion intermediate does 
not exist. 
Fast reaction kinetics 
Temperature jump experiments on GOT in the presence of each amino 
acid-keto acid pair were performed by Fasella and Hammes (1967). 
Three relaxation processes were observed for each half reaction: 
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lower bounds of 10^ - 10^ sec~^ and 10^ - 10^ sec"^ were estimated 
for the rate constants associated with the bimolecular and dissociation 
processes involving amino acids while the corresponding lower bounds 
for keto acids were 10^ M"^ sec~^ and 10^ sec"\ The wavelength 
dependence of the amplitudes of the relaxation effects was also in­
vestigated; intermediates absorbing at 360, 430, and 490 mp were 
suggested to occur on one side of the slow step and an intermediate 
absorbing at 330 mu to be on the other side. This conclusion is 
supported by use of the pseudosubstrates a-methylaspartate and 
e-hydroxyaspartic acid in equilibrium studies; the former which can 
combine with GOT as a Schiff base, but cannot transaminate, has 
absorption peaks at 430 and 365 mp (Fasella, et , 1966) while the 
latter compound exhibited an intermediate absorbing at 490 mu (Jenkins 
and Taylor, 1965; Jenkins, 1961, 1964). 
Equilibrium studies 
Jenkins and coworkers (1965, 1966a) demonstrated that the amino 
acid substrates do not complex with the aminic enzyme, while the keto 
acid substrates react with the aldiraine enzyme (predominately with 
the protonated enzyme but also somewhat with the nonprotonated GOT) to 
form abortive complexes. Furthermore, the enzyme-substrate inter­
mediates were shown to have absorption maxima at 490, 430, 365, and 
330 my by combining spectroscopic analyses with kinetic methods. These 
authors suggest that the 430 and 360 my absorbancies are due to aldimine 
derivatives, while the absorbancy at 330 my Is due to ketlmine 
derivatives or to tetrahedral addition products between PLP and amino 
14 
acids. The 490 mu absorbing species has been suggested to have a 
quinoid structure (Jenkins, 1964) as shown below. 
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Equilibrium studies have also been performed on pseudosubstrates. 
Two of these (a-methylaspartate and B-hydroxyaspartate) were mentioned 
above under fast reaction kinetics. The erythro and threo isomers of 
B-hydroxyglutamate were investigated by Khomutov and others and 
reported by Fasella (1968). Both isomers reacted with GOT rapidly 
to form a 490 my absorbing species followed by slow transamination. The 
threo isomer produced a larger amount of quinoid intermediate than 
did the erythro. These results suggest, in the case of the normal 
substrates, that a proton removed from the a-carbon to form the quinoid 
intermediate would then be transferred to the 4'-carbon atom of the 
coenzyme to give the ketimine. 
The binding of glutaric acid to GOT has been studied by Jenkins 
and D'Ari (1956b). One carboxylate group of glutaric acid is bound 
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to the protein by displacement of a buffer anion; the other is bound 
at low pH values, but not at high pH. The binding site of the second 
carboxylate group is thought to be the quaternary nitrogen atom of 
the protonated lysyl e-amino group that is involved in the aldimine 
linkage between the protein and the aldehyde group of pyridoxal phos­
phate. Jenkins and D'Ari (1966b) further state that there is no 
protein conformational change upon binding of substrate, but that a 
configurational change in the substrate is required and that the 
ability to undergo this change determines the substrate specificity. 
An intriguing study of the stereochemistry of the transamination 
reaction has been recently undertaken by Dunathan and coworkers (1966, 
1968a, 1968b). The 1,3-prototropic shift of the tautomerism of the 
amino acid aldimine to the ketimine intermediate must occur within 
—'the confines of five stereochemical variables: a) the configuration 
of the a-carbon of the amino acid (Cp), b) the configuration of the 
proton added to the 4'-carbon of the coenzyme (C^i), c) the conformation 
about the C-N single bond, d) the conformation of the C^i = N double 
bond, and e) the stereochemistry of the proton transfer (called "cis" 
if the CH bond making and breaking both occur on the same side of the ir 
system plane or "trans" if on opposite sides). The first variable (a) 
is known for L-amino acids and the third (c) was assumed to be trans 
by Dunathan. Progress in determining (b) and (e) was reported for GOT 
(Dunathan, 1968a, 1968b) and for pyridoxamine-pyuvate transaminase 
(Ayling et , 1968); investigation of the latter enzyme Indicated a 
"cis" removal and addition of a proton presumably by a single group of 
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the enzyme which functions as a general acid-base catalyst. 
Thus, in spite of the complex nature of an enzyme-catalyzed 
reaction, a detailed picture of GOT's mode of action in terms of 
substrate binding, formation and tautomerization of the Schiff bases, 
and release of product is emerging. 
Coenzyme Binding 
From its extensive role in GOT's catalytic action, it is obvious 
the PLP is bound to the protein in a highly specific manner. The 
nature of the coenzyme's binding has been the subject of much investi­
gation and controversy. The discovery that PLP was bound to the protein 
as a Schiff base with the E-amino group of a lysine resideu (Hughes 
et , 1962) raised objections to the proposed formation of enzyme-
substrate complexes as Schiff bases {Evangelopoulos and Sizer, 1963). 
However, imine formation was found to enhance the reactivity of PLP 
toward carbonyl reagents (Cordes and Jencks, 1962); furthermore, amino 
acids and many carbonyl reagents reacted more readily with the bound 
PLP of GOT than with free PLP (Jenkins e^ aj^., 1959a). 
Spectral and chemical evidence indicated that PLP could be bound 
to the E-amino group of a protein in at least three ways: 1) as a 
protonated imine with an absorption maximum in the 410-430 mp region, 
2) as a nonprotonated imine with an absorption maximum at about 360 mu, 
and 3) as a substituted aldimine with an absorption maximum at about 
330 mp. The latter mode of binding does not permit reduction by sodium 
borohydride or react with carbonyl reagents (Fischer et al., 1963) and 
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is not present in catalytically active GOT (although it most likely may 
be responsible for the inactive y-subform). GOT exhibits pH dependent 
absorption spectra that are characteristic of the unsubstituted imines 
from which Jenkins and coworkers (1959b) obtained a pK value of 6.3 
for the protonation of the PLP-protein imine of GOT. 
Other optical properties of the bound coenzyme have been studied. 
PMP has a characteristic luminescence spectrum which is quenched when 
bound at the active site, but not when bound in an unspecific manner to 
other proteins (Churchich, 1964). A positive Cotton effect is associated 
with bound PLP and is centered about the coenzyme's absorption band as 
shown by optical rotatory dispersion (Fasella and Harrmes, 1965) and 
circular dichroism (Breusov et al., 1964). The Cotton effect is 
diminished by substrate, carbonyl reagents, borohydride reduction, 
and concentrated urea. These studies have emphasized the highly 
specific nature of the enzyme-coenzyme interaction. 
Analogs of PLP have been utilized for a definition of the structural 
requirements of the coenzyme. Morino and Snell (1967) reported that 
u-methyl-pyrodoxal phosphate and norpyridoxal phosphate reactivated 
apoGOT (see Table 1 for structures of these derivatives); hence, the 
methyl group is not required for catalysis. 0-methyl-pyridoxal phosphate 
(see Table 1) did not reactivate GOT, but whether the reason lies in its 
failure to combine with or to activate apoGOT has not been determined. 
ApoGOT was found to catalyze the two half reactions (1) and (2) 
(Wada and Snell, 1962) 
Table 1. Activity of pyridoxal analogs as substrates for pyridoxamine pyruvate transaminase 
(Ayling and Snell. 1968) 
Active 
Structure Name Substituents as 
R R' R" Substrate 
CHO A. Pyridoxal CH3 OH CHgOH Yes 
0 
rR" B. u)~Methyl pyridoxal CH3CH2 OH CH2OH Yes 
A -l C. Norpyridoxal H OH CHgOH Yes 
CHO 
D. 5-Deoxypyridoxai CH3 OH CH3 Yes 
-0. 
9 
rCHgOH 
E. 3-Hydroxy-4-pyri di ne 
aldehyde H OH H Yes 
J F. Pyrodixal phosphate CH3 OH CH2OPO3 (Yes) 
CH 3 6. 3-Deoxypyridoxal CH3 H CHgOH No 
CHO H. Pyridine-4-aldehyde H H H No 
HO-
V 
1 K 
I. 0-Methylpyridoxal CH3 OCH3 CH2OH No 
J. N-Methylpyridoxal (see column I) No 
NO 2 K. 4-Nitrosalicylaldehyde (see column I) No 
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(1) Pyridoxal and glutamate t pyridoxamine and a-ketoglutarate 
(2) Pyridoxamine and oxaloacetate ^  aspartate and pyridoxal 
by using substrate-level concentrations of pyridoxal and pyridoxamine. 
The value for pyridoxal (about 2.5 mM) was given as about 1.7 x 10^ 
times higher than that for PLP (Kp^^p = 0.15 wM); this showed the tre­
mendous effect of the 5'-phosphate of PLP upon the affinity of the 
coenzyme for apoGOT. These authors also concluded that the phosphate 
group played only a binding role and was not required for enzymic 
transamination. Because of the low affinity of apoGOT for non-
phosphorylated pyridoxal analogs, Ayling and Snell (1968) utilized 
pyridoxamine pyruvate transaminase which catalyzes reaction (3) and which 
(3) Pyridoxamine and pyruvate t pyridoxal and L-alanine 
has high affinity for pyridoxal and pyridoxamine to analyze the effects of 
several pyridoxal analogs as shown in Table 1. Compounds A through E were 
excellent substrates, F was poor, while G through K were inactive as sub­
strates. These investigators also obtained dissociation constants for 
each analog. Their conclusions are summarized as follows. 
1) Neither the 2-methyl group or the 5-hydroxymethyl of pyridoxal 
plays a role in transamination. 
2) The substituent at position 2 of the analogs strongly affects 
binding to the enzyme. 
3) Removal of the 5 substituent affects binding to a lesser extent. 
4) A phenolic group in the 3 position is required for efficient 
binding and seems to be essential for transamination. 
20 
5) The minimum structural requirements are met by 3-hydroxy-
py ridine-4-aldehyde. 
In brief, the essential structural features of pyridoxal required 
for enzymic transamination are the same as those required for nonenzymic 
transamination in aqueous solutions: a formyl group adjacent to a 
phenolic group and conjugated to the electron-withdrawing heterocyclic 
nitrocyclic nitrogen of the pyridine ring (Metzler et , 1954). 
21 
EXPERIMENTAL 
Materials 
Pyridoxal phosphate analogs 
Carboxymethyl-deoxypyridoxal and the corresponding amine were 
synthesized by Dr. Chuzo Iwata of this laboratory. The syntheses have 
been described (Iwata and Metzler, 1967). 
The phosphonic acid derivative of deoxypyridoxal was also supplied 
by Dr. Iwata. The synthesis has not been described in the literature. 
Deoxypyridoxal was synthesized by Mr. Robert J. Johnson of this 
laboratory using the method of Iwata (1968). 
Pyridoxal hydrochloride and pyridoxal phosphate were obtained from 
Sigma Chemical Company. 
The methyl phosphonic acid of PLP and the cyanoethyl ester of PLP 
were prepared by Dr. Walter Korytnyk, Departnœnt of Experimental 
Therapeutics, Roswell Park Memorial Institute, Buffalo, New York. 
N-methyl-PLP was synthesized by Dr. Anna Pocker of the Department 
of Biochemistry, University of Washington, Seattle, Washington and was 
the generous gift of Dr. Esmond E. Snell of the Department of Bio­
chemistry, University of California, Berkeley, California. 
PLP-N-oxide was synthesized and supplied by Dr. Saburo Fukui of 
the Department of Industrial Chemistry, Kyoto University, Kyoto, Japan. 
The synthesis has been described (Ohishi, et a1^., 1968). 
Buffers and other chemicals 
Buffers, substrates, inhibitors, and other chemicals were obtained 
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from commercial sources. Triethanolamine hydrochloride was prepared by 
dissolving reagent grade triethanolamine in a minimal amount of water 
in the presence of an excess of HCl, precipitating the hydrochloride 
salt with addition of ethanoî (75% v/v, final concentration}» and 
recrystallizing three times from water-ethanol. Glutaric acid was 
recrystallized three times from benzene after treatment with activated 
charcoal. All other chemicals were reagent grade. 
Enzyme 
Fifty pound lots of fresh pig heart were obtained from Des Moines 
packing plants and trimmed free of auricles and fat and minced in a 
meat grinder. Two kilogram portions of minced muscle were combined 
with two liters of 0.05 M glutarate, 0.005 M EDTA buffer, pH 6.0, and 
homogenized for sixty seconds in a chilled one gallon Waring blender. 
The thick homogenate was transferred to stainless steel beakers in an 
85° water bath and stirred continuously. When the temperature of the 
homogenate reached 50°, solid a-ketoglutarate (0.5 g. per 8 1.) 
was stirred in to maintain the enzyme in the aldehyde form. When the 
temperature of the homogenate reached 75° (about 20 minutes) the 
temperature of the bath was reduced to about 77° and the homogenate 
was allowed to remain at 75° for twenty minutes with intermittent 
stirring. The denatured protein and other solids were removed by 
straining through a cheesecloth bag and the supernatant was cooled to 5°. 
Solid anïïnonium sulfate (310 g. per 1., 50% saturation) was added to the 
chilled supernatant and the precipitate was collected by centrifugation. 
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The precipitate was discarded and additional ammonium sulfate (150 g. 
per U» 72.5% saturation) was added to the supernatant. The yellow 
precipitate was collected by centrifugation and was taken up in 0.02 M 
glutarate buffer, pH 6.0» and dialyzed overnight against water in the 
cold. After dialysis fifty moles of a-ketoglutarate were added to the 
preparation and the solution was made 0.08 M in phosphate, pH 6.8. 
This preparation was applied to a hydroxy1apatite column (4.5 x 15 cm) 
which had been previously equilibrated with water. The hydroxy1apatite 
was prepared by the method of Jenkins, (1960). After the column had 
drained, the yellow band of GOT was eluted with 0.08 M phosphate, pH 6.8, 
and the elutent was collected with a fraction collector. The bright 
red-yellow fractions containing the enzyme were pooled, concentrated 
by ammonium sulfate precipitation (500 g. per 1.), and dialyzed against 
0.04 M acetate, pH 5.4. The major subforms were separated on a 
carboxymethyl Sephadex (CM-50) column (1.5 x 30 cm) which had been 
equilibrated with 0.04 M acetate, pH 5.4. After allowing the enzyme 
to absorb slowly into the column, the column was washed with 100 ml. 
of 0.04 M acetate, pH 5.4. The y-fraction was completely removed and 
separation of the B-60T from the a-GOT was performed by elution with 2 
liters of 0.06 M acetate, pK 5.4. The separated a and g forms were 
eluted with a linear gradient from 0.06 M to 0.11 M acetate (one liter 
each solution). Fractions containing the a-subform were collected, 
concentrated by anmonium sulfate precipitation, and stored in 0.01 M 
acetate, pH 5.4. 
The a-GOT used for the major amount of experimental results 
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presented in this dissertation was prepared as above by Dr. W. Terry 
Jenkins of the Department of Chemistry» Indiana University, Bloomington, 
Indiana and very generously given for this study. This preparation 
had an absorption ratio (430 my/340 my) of 4.3 in 0.8 M acetate, pH 4.8, 
and a specific activity of 40.4 mM/min./mg. 
Methods 
Resolution 
The native enzyme was resolved by the method of Scardi et al. 
(1963). For a typical preparation twenty-four ml. of 0.2 M 
L-glutamate, pH 8.3, were added to one ml. of a-GOT stock solution 
(35 mg. per ml.); this solution was allowed to remain at room temperature 
for ten minutes to produce the amine form of the enzyme. Twenty-five 
ml. of 1.0 M phosphate, pH 4.8, was then added and the preparation 
was incubated at 30° for thirty minutes. After incubation the protein 
was precipitated by addition of 150 ml. of saturated ammonium sulfate. 
The precipitate was collected by centrifugation, taken up in 0.01 M 
triethanolamine HCl, pH 8.3, and the incubation with phosphate with 
subsequent precipitation repeated. This precipitate was also dissolved 
in 0.01 M triethanolamine HCl and passed through a short (1.5 x 10 cm) 
G-25 Sephadex column to remove the remaining ammonium sulfate. If a 
significant amount of absorption at 330 my (greater than one-fortieth of 
the absorption at 280 my) was detected in the preparation, the incubation 
procedure was repeated once more. 
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The resolved GOT preparations utilized for cofactor studies had an 
absorption at 330 mu of less than one-fortieth than that at 280 mu 
and no enzymic activity. These preparations could be reactivated with 
PLP to 90-99% of the activity of the native enzyme. 
Reduction 
The aldimine linkage between some cofactors and the protein was 
reduced with sodium borohydride. Solid NaBH^ (one mg. per ml.) was 
added to enzyme solutions in 0.1 M triethanolamine HCl, pH 8.3, at 0° and 
the solution was dialyzed against 0.01 M triethanolamine HCl, pH 8.3, 
overnight. 
Spectrophotometric measurements 
Absorption spectra were obtained on a Gary 15 recording spectro­
photometer equipped with a digital output device which recorded spectral 
data directly on punched cards. Those spectra which were recorded on 
cards were available for normalization with respect to protein con­
centration by computer. Computer treatment of data was performed by 
Mr. Robert J. Johnson of this laboratory. 
Circular dichroism was measured In some preparations with a 
modified Jouan dichrograph described by Johnson and Graves (1956) with a 
sensitivity of approximately 2 x 10"^ absorbance units under the con­
ditions employed. A Jasco Model ORD/UV-5 with CD attachment was utilized 
for the remainder of the CD spectra. Fluctuations in the recorder tracings 
were 1.0 x 10"^ or less. While the instruments were calibrated to ^  1 
my, peak positions could not be determined to this accuracy (especially 
the low, broad peaks). The peak positions reported are approximately 
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5 mu. Solutions of five to ten mg. per ml. in protein were used. 
Assay 
Routine assays were performed by the method of Jenkins et (1959b). 
Enzyme (0.1 ml.) was added with an adder-mixer to a cuvette containing 
200 ymoles of tris(hydroxymethyl)aminomethane, pH 8.3, 20 umoles of 
a-ketoglutarate, and 20 umoles of L-asparate in a total volume of 3 ml. 
Oxaloacetate produced was followed at 280 mu utilizing a Beckman DU 
equipped with a Gilford Model 220 absorbance indicator and automatic 
recorder with multispeed chartdrive. The absorption coefficient of 
oxaloacetate as given by Velick and Vavra (1962) (0.57 mM~^ cm~^) was 
used to express activity as mM/min. per mg. of enzyme. 
Assays for amino acid substrates and some kinetic studies utilized 
oxaloacetate and L-glutamate as substrates. In these assays the decrease 
of oxaloacetate was followed and the activity was expressed as above. 
Protein concentration 
Protein concentrations were determined by measuring the absorbancy 
at 280 mu. A solution of 0.74 mg./ml. of apoenzyme has an absorbancy 
of 1.0; for the holoenzyme, the value is 0.71 mg./ml. (Banks, et al., 
1968c). 
The molecular weight was assumed to be 4 x 10^ g./mole per mole of 
coenzyme (Banks, et 1968c). 
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RESULTS 
Spectral data are presented here by illustrating each entire 
absorption or CD spectrum within the wave-length range of 300 to 500 my. 
A summary of spectral and enzymic data is presented at the end of this 
section. Where appropriate, the spectra have been corrected for dilution. 
I and II Pyridoxal Phosphate 
and Pyridoxamine Phosphate 
Native GOT 
For purposes of comparison, data on the PLP-containing native 
enzyme are included. The pH dependence of the enzyme's (a subform) 
absorption spectrum is shown in Figure 2. The corresponding CD 
spectra (Figure 3) were obtained on a GOT preparation in which the 
subforms had not been separated (the my^'^340 mu ratio was 1.2 at 
pH 4.8). The spectra of the abortive complex formed between a-GOT 
(aldehyde species) and a-ketoglutarate are illustrated in Figures 4 and 
5. The absorption and CD spectra of the PMP form of the enzyme, shown 
in Figure 6, were obtained on a preparation of GOT in which the subforms 
had not been separated (the A^^o my^^340 mp ratio was 1.2 at pH 4.8). 
The reactivity of a-GOT toward L-glutamate at a saturating level of 
oxaloacetate (halving the oxaloacetate concentration had no effect on 
the initial velocity) was investigated. From the abscissa intercept 
and the slope of a double reciprocal plot of 1/V^ vs 1/S (Lineweaver-
Burke plot. Figure 7), a value of 2.15 (+0.5) mM was obtained for 
^Glu* This value was in close agreement with that (4 mM) of Velick and 
Figure 2. Absorption spectra of a-GOT in 0.1 M acetate, pH 5.20, and in 
0.01 M triethanolaraine HCl, pH 8.33, (solid lines); and 
apoGOT in 0.01 M triethanolaraine HCl, pH 8.3, (broken line). 
Protein concentrations are 7.5 x 10"^ M 
Figure 3. CD spectra of cytoplasmic GOT (subforms not separated; 
^430 mp^^340 mp ~ pH 4.8) in 0.01 M acetate, pH 4.8, 
and in 0.001 M triethanolamine HCl, pH 8.3. At pH 4.8, 
AA/A = 3.2 X 10-3 AT 430 my; at pH 8.3, ûA/A =2.0 x 10"^ 
at 362 my. Protein concentration is 1.3 x 10" M 
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Figure 4. Absorption spectra of a-GOT-a-ketoglutarate complex in 0.1 
M acetate, pH 5.4, and in 0.01 M triethanolamine HCl, 
ph 8.3, a-ketoglutarate concentration is 5.0 x 10"^ M. 
Protein concentration is 7.2 x 10"^ M 
Figure 5. CD spectra of a-GOT-a-ketoglutarate complex in 0.1 M 
acetate, pH 5.4, and in 0.01 M triethanolamine HCl, ph 8.3. 
At pH 5.4, AA/A = 2.5 x 10"^ at 435 my; at pH 8.3, AA/A 
= 1.9 x IQ'3 at 365 my. a-ketoglutarate concentration is 
5.0 X 10"^ M. Protein concentration is 7.2 x 10"^ M 
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Figure 6. Absorption spectrum (solid line) and CD spectrum (broken 
line) of the PMP form of cytoplasmic GOT (see legend for 
Figure 3, page 28) in 0.001 M triethanolamine HCl, pH 8.3. 
Concentration of L-glutamate is 0.01 M. AA/A = 1.5 x 10~3 
at 330 mu. Protein concentration is 1.3 x 10"^ M 
Figure 7. Lineweaver-Burke plot of a-GOT where S is the concentration 
of L-glutamate in mM and is the initial velocity in 
mM/min/mg. Concentration of oxaloacetate is 0.667 mM 
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Vavra (1962) who utilized a GOT preparation containing all subforms. 
apoGOT-I 
PLP was bound very rapidly by apoSOT to form a complex whose 
absorption spectra closely approximated that of the native enzyme. 
However, the absorption at 410-420 mu was higher for the reactivated 
apoGOT than it was for the native GOT. The apoGOT-I possessed a 
specific activity of 92-99% of the specific activity of native GOT. 
Ill Carboxymethyl-deoxypyridoxal 
Binding 
ApoGOT at a concentration of 8.9 x 10"^ M was allowed to react with an 
excess of III (2.0 x 10"^ M) and was then passed through a short column 
(1.5 X 15 cm) of Sephadex G-25. Two distinct yellow bands were formed, 
one corresponding to the protein fraction and the other to free III. 
The protein-bound III exhibited an absorbance maximum at 370 my, a shift 
of 20 mp from that of the unbound compound. The absorbance ratio, 
Aggg mp/^SZO mp* apoGOT-III was 10.5 from which it was assumed that 
amount of III bound was about the same as that of PLP in the native 
enzyme. To confirm this, a stoichiometric amount of III was added to 
apoGOT and the same spectrum was obtained. Thereafter, apoGOT-III was 
prepared by allowing an approximately equal molar amount of III to 
combine with apoGOT (Figure 8). ApoGOT-III displays circular dichroism 
as shown in Figure 9. The bound III gave two peaks, a positive one at 
-3 362 my with a Kuhn dissymmetry factor (AA/A) of 1.6 X 10" and a negative 
one at 412 my. The amount of absorbance and CD at 412 my varied in the 
Figure 8. Absorption spectra of III (broken line) and apoGOT-III 
(solid line) in 0.01 M triethanolamine HCl, pH 8.3. 
Concentration of III is 6.0 x 10"^ M. Protein concentra­
tion is 5.3 X 10"^ M 
Figure 9. CD spectrum of apoGOT-III in 0.01 M triethanolamine HCl, 
pH 8.3. Concentration of III is 1.0 x 10"^ M. Erotein 
concentration is 9.3 x 10" M. AA/A = 1.6 X 10" at 
362 my 
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different preparations of apoGOT-III. ApoGOT-III did not show any pH 
dependent change in the absorption or CD spectra over the range of pH 
5.4 to 8.3. 
The apoGOT-III complex may be reduced with sodium borohydride 
giving rise to a maximum at 332 my in the absorption and CD spectra 
(AA/A was 7.4 X 10"^ and the A^^_ /A^ ^ ratio was 5.03; Figure 
280 my 332 my 
10a). Incubation with an excess of PLP followed by dialysis reactivated 
the reduced apoGOT-III slightly with a specific activity of 0,16 
mM/min/mg, a result which was expected since the borohydride reduction 
is usually accompanied by some resolution of the enzyme. Under the same 
conditions a control of apoGOT was activated by PLP to an activity of 
8.8 rrW/min/mg. The spectral characteristics of reduced apoGOT-III 
in the presence of PLP are interesting. A ten-fold excess of PLP was 
added to three ml. of reduced apoGOT-III (3.27 mg/ml) and the solution 
was dialyzed against 0.001 M triethanolamine HCl overnight. Under these 
conditions, the CD at 332 my was destroyed and a small negative peak 
AA/A = 1.57 X 10"^) at 414 my appeared (Figure 10b) while the 
absorption spectrum showed two peaks with maxima at 325 my and 390 my. 
The complex had no additional enzymic activity (0.17 mM/min/mg). 
Reduction of this complex with sodium borohydride followed by dialysis 
gave absorption and CD peaks at 325 my and 329 my respectfully (Figure 
10c). 
Information regarding the binding constant of III relative to that 
of PLP and the rate constant of the dissociation of III from the enzyme 
was obtained by observing the displacement of III by PLP. For the 
Figure 10a. Absorption and CD spectra of reduced apoGOT-III in 
0,001 M triethanolamine HCl, pH 8.3, AA/A = x 10" 
at 332 mu. Protein concentration is 8.2 x 10"^ M 
Figure 10b. Absorption and CD spectra of reduced apoGOT-III after 
addition of PLP in 0.001 M triethanolamine HCl, 
pH 8.3. AA/A = 1.7 x 10"]cat 414 mu. Protein 
concentration is 8.2 x -0" M 
Figure 10c. Absorption and CD spectra of complex shown in Figure 10b 
after reduction with sodium borohydride in O.OQl M 
triethanolamine HCl, pH 8.3. AA/A = 1.9 x 10" at 329 mu. 
Protein concentration is 5.3 x 10" M 
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relative binding constant data, a stoichiometric amount of PLP was 
added to apoGOT-III (the final concentration of each was 2.0 x 10"^ M) 
and the subsequent reactivation of the enzyme at 25° followed by 
activity assays (Figure 11). The relationship between the dissociation 
constants and the activity may be derived as follows. 
From 
EI ^  E + I and FTTT ^  F  +  I T T  ( 1 )  
the two dissociation constants are defined as 
Kj = [E][I]/[EI] and Kjjj = [E][III]/[EIII] (2) 
Dividing Kj by Kjjj, 
K [EIII][I] 
i_ (3) 
KJII " [EI][III] 
Since the total amount of enzyme [Ey] is equal to the sum of all forms 
of E and assuming that there is no E that is not combined with one of 
the cofactors, then 
[EIII] = [E^] - [EI] (4) 
Substituting (4) into (3) and rearranging gives 
The maximum activity possible is proportional to [Ej] and the 
observed activity at equilibrium is proportional to [EI] since 
EIII is virtually inactive at the low concentration used. Hence, 
Figure 11. Plot of reactivation of apoGOT-III by PLP. V; is the initial 
velocity in mM/tnin. Concentrations of III and PLP are 
2.0 X 10"° M each. Protein concentration is 1.8 x 10"" M. 
^obs the initial velocity of apoGOT-III plus PLP at 
equilibrium and 4^=% is the initial velocity of an eqj^al, 
amount of apoGOT plus PLP only 
-5 
Figure 12. First order plot of reactivation of apoGOT-III by an excess 
of PLP. the initial velocity at time t in absorbance 
units/sec., minus Va,, the initial velocity at equilibrium, 
is plotted on a log-iQ scale. Concentrations of III, PLP, and 
protein are 1.0 x 1Ô-6 m, 2.5 x 10"5 M, and 9.4 x 10"' M 
respectively 
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In this experiment A = 0.079 mM/min. which is the activity of a 
ulaX 
control solution of apoGOT plus PLP at a concentration of 2.0 x 10"^ M 
and Agbs is the competition equilibrium activity of 0.056 mM/min. 
[Ill] is equal to 2.0 x 10"^ M - [EIII] and [I] is equal to 2.0 x 10~® M 
- [EI]. [EI] and [EIII] were determined from 
[E'] ' Aobs/Amax X [Ey] . 1.28 x lO'S M (7) 
[EIII] = [Ej] - [EI] = 0.52 X 10-6 ^  (8) 
Substitution into (6) gives — 
0.079 2.0 X IP-G - 0.52 x lO'^ ,gx 
0.056 2.0 X 10-G - 1.28 x 10"^ 
Kj = 0.19 Kjjj 
Therefore, III is bound approximately one-fifth as tightly as PLP. 
While this result is subject to several errors (denaturation of protein, 
determination of protein and cofactor concentrations, and activity 
measurements), the tighter binding of PLP compared to that of III is 
confirmed by the fact that III caused no loss of enzymic activity when 
Incubated with native GOT at 5° during periods of up to ten days. 
The rate constant of the dissociation of III from apoGOT-III at 
25° was evaluated by reactivating the enzyme with a large excess of PLP 
(Figure 12). 
For the reactions 
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EIII^==Ç=^III + E (10) 
E + I » El 
the following conditions hold 
[Ey] = [EIII] + [E] + [El] (11) 
d[Ey] d[EIII] d[E] d[EI] 
dt dr~ ~dF" •*" ~dt (TZ) 
Assuming a steady-state existence for E (d[E]/dt = 0), 
d[EI] _ dÇEIin 
dt dt 
and, as a further consequence of the steady-state assumption, 
' yïïSSïT 
substituting for [E] 
(13) 
(14) 
d[EI] k^kjCllCEIII] (15) 
dt kgClIin+kgCl] 
From (13) and (15) 
d[EI] dCEIII] k^k^Cl3[EIIl3 (16) 
dt dt k^ClIIl+k^El] 
When kgCl] » k2ClII] (by making [I] » [III]) 
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d[EI] d[EIII] k,k.[I][EIII] ,171 
Therefore, when [I] >> [III]» the slope of a first order plot 
(In A^/A^ vs. time) is equal to k-j, the rate constant for the dissociation 
of apoGOT-III. From Figure 12, k-j = 2.303 x slope = 2.83 x 10~^ sec"^. 
The half-life, t^^g, of the dissociation is given by 
hn - ^  2.83'fl0-4 = 2-44 X 10^ sec = 41 min. 08) 
Reaction with substrates 
ApoGOT-III showed a small amount of catalytic activity in the usual 
assay (20 ymoles each of L-aspartate and a-ketoglutarate, 200 umoles 
Tris, pH 8.3; 3 ml.); at 5.5 x 10"^ M the activity was 0.095 mM/min/mg 
which is only 0.23% of the activity (41.0 mM/min/mg) exhibited by 
PLP-reactivated apoGOT at a concentration of 5.5 x 10"^ M. However, the 
addition of 0.1 ml of 0.2 M L-glutamate to 1.0 ml of 6.0 x 10"^ M 
apoGOT-III in a cuvette caused a rapid decrease in the 370 my peak 
(Figure 13) and the formation of a peak at 320 my. About 94% of the 
370 my peak disappeared within two minutes followed by a slower approach 
to the equilibrium position shown in Figure 13. The absorption at 412 my 
decreased also but twice as slowly as the 370 my absorption. After 28 
minutes, 0.1 ml of 0.1 M a-ketoglutarate, pH 4.8, was added to the cuvette 
which caused the 320 my peak to rapidly shift to 323 my and slowly 
decrease to form a peak at 375 my. The absorption spectrum shown in 
Figure 13 was obtained 20 minutes after the addition of a-ketoglutarate. 
Figure 13. Absorption spectra of apoGOT-III and III after reaction with 
substrate. 
apoGOT-III, pH 8.3 (no substrate) 
apoGOT-III in 1.82 x ID"! M L-glutamate, pH 8.3 
apoGOT-III ir> K66 x 10" M L-glutamate 
and 8.3 X 10" M a-ketoglutarate, pH 6.5 
Ill in 1.82 X 10"2 M L-glutamate, pH 8.3 
Concentration of III is 6.0 x 10"^ M. Protein concentra­
tion is 5.3 X lOrS M. All pK 8.3 solutions are in 0.01 M 
triethanolamine HCl 
Figure 14. Lineweaver-Burke plot of apoGOT-III where S is the concentra­
tion of L-glutamate in ntfl and is the initial velocity in 
mM/min/mg. Concentration of oxaloacetate is 0.667 mM 
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and 30 hours of incubation at room temperature resulted in a 
A223 mu ratio of 1.2. The final pH of the solution was 6.5 
L-aspartate also caused the absorption to shift from 370 my to 320 mu 
and this change could be reversed by a-ketoglutarate or oxaloacetate. 
The species absorbing at 320 mu showed very little CD and was 
not bound firmly to the protein. When aspartate-treated apoGOT-III 
containing this species was passed through a short column of Sephadex 
G-25, the Aggg mu/^320 mu^^^^° increased from 4.5 to 13.2, which 
indicated a substantial loss of chomophore. Since the above results 
suggested that apoGOT-III undergoes transamination—in a manner 
analogous to that of the native GUT~to give carboxymethy 1-
deoxypyridoxamine, a solution containing apoGOT (6.9 x 10'^ M) and 
synthetic carboxymethyJ-deoxypyridoxamine (5.3 x 10"^ M) in 10"^ M 
triethanolamine HCl, pH 8.3, was prepared. This preparation, after 
standing at room temperature for 24 hours, demonstrated the same 
characteristics (absorption spectrum, CD, looseness of binding) as that 
of the aspartate- or glutarate-treated apoGOT-III and was converted 
by a-ketoglutarate and oxaloacetate to a form absorbing at 370 mu. 
Since III appeared to be bound at the active site in a specific 
manner, the low rate of apoGOT-IIl-catalyzed transamination was of 
interest. In order to determine whether the amino acid substrate was 
allowed to bind properly or not, the reactivity toward L-glutamate at a 
saturating level of oxaloacetate was investigated and a Lineweaver-Burke 
plot constructed (Figure 14). While V-j, the maximum velocity, was one 
hundredth of that of a-60T (0.735 mM/min/mg for apoGOT-III, 74 
mM/min/mg for a-GOT), the Michaelis constant for glutamate, was in­
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creased only 5.7 times = 12.2 (+ 1.8) mM for apoGOT-III, 2.15 mM 
for a-GOT)c Because of the low initial velocities and inhibition by 
a-ketoglutarate (see below), the L-aspartate--a-ketoglutarate substrate 
pair could not be utilized for such a study. 
The reactivity of apoGOT-III toward some amino acids and some 
common inhibitors of GOT was investigated and compared with that of 
a-GOT as shown in Table 2. Substrate inhibition of apoGOT-III by 
a-ketoglutarate was very pronounced even at a high level of L-aspartate 
(Table 3) and is much higher than that shown by GOT (Velick and Vavra, 
1962). The complex formed between apoGOT-III and a-ketoglutarate 
absorbed light at 380 mu and possessed CD (M/A = 7.1 x 10"^) at 372 mu 
at pH 8.3 (Figures 15 and 15). Furthermore, the complex's CD spectrum 
was pH dependent with a peak at about 450 mp appearing at pH 5.4. 
Unfortunately, the complex was quite unstable at the lower pH and the 
absorption spectrum at pH 5.4 does not yield much information on the 
pH dependence. 
The behavior of III with amino acids was briefly investigated. 
Ill in the presence of L-glutamate absorbed light at 415 my (Figure 13); 
no absorption at 320 mu appeared in a five hour period. With 
1-0 x 10"^ M III in 0.01 M L-aspartate in 0.01 M triethanolamine HCl, 
pH 8.3, no signiTîcànt amount of 320 mu absorbing species was produced 
unless incubated for at least 72 hours at room temperature. 
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Table 2. Substrate and inhibitor specificity of apoGOT-III 
Substrate (s) or a-GOT^ apo-GOT-
Inhibitor (i) Sp. Activity 
(mM/min/mg) 
% of 
maximum 
activity 
Sp. Activitv 
(mM/mi n/mgj 
' % of 
! maximum 
activity 
L-glutamate^(s) 66.7 (100) 0.46 (100) 
D-glutamate^(s) 0 0 0 0 
L-alanine^(s) 0 0 0 0 
L-valine^Cs) 4.0 6.0 0.17 37.0 
L-serine^fs) 0 0 0 0 
L-methionine^(s) 0 0 0 0 
a-Methyl-D,L-
aspartate (i) 28.5 42.7 0.17 37.0 
glutarate®(i) 45.7 68.6 0.23 50.0 
adipate®(i) 54.3 81.5 0.20 43.5 
succinate®(i) 54.3 81.5 0.20 43.5 
L-aspartate^(s) 40.5 - 0.095 -
D-aspartate^(s) 0 0 0 0 
a-Methyl-D,L-_ 
aspartate (s) 0 0 0 0 
^0.0035 mg used in each assay. 
^0.035 mg used in each assay. 
^20 wmoTes amino acid, 2 ymoles oxaloacetate, 200 pmoles Tris, pH 
8.3, volume 3 ml. 
^40 pmoles inhibitor (20 pmoles each isomer). 
^20 pmoles inhibitor, 20 ymoles L-glutamate, 2 ymoles oxaloacetate, 
200 ymoles Tris, pH 8.3, volume 3 ml. 
^20 pmoles amino acid, 20 pmoles a- ketoglutarate, 200 ymoles Tris, 
pH 8.3, volume 3 ml. 
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Table 3. Inhibition of apoGOT-III by a-ketoglutarate^ 
a-ketoglutarate Specific Activity 
(mM) (mM/min/mg) 
6.67 
3.33 
2.00 
0.667 
0.333 
0.200 
0.093 
0.133 
0.158 
0.200 
0.225 
0.268 
a 
0.035 mg of apoGOT-III used in each assay. All assays were 
6.67 mM in L-aspartate and 66.7 mM in Tris, pH 8.3; volume 3 ml. 
IV Deoxypyridoxalyl Phosphonic Acid 
Binding 
ApoGOT (9.3 X 10"5 M) WAS combined with IV (1.0 x 10"^ M) in a 
cuvette at pH 8.3; within two minutes the absorption maxima of the 
unbound IV at 369 and 325 mw were destroyed and absorption maxima at 
420 and 359 m# appeared (Figure 17). Addition of 1.0 M acetate buffer, 
pH 5.4, (to a final concentration of 0.1 M) caused a decrease in the 
absorption at 359 my and an Increase at 430 rop. The corresponding CD 
spectra are shown in Figure 18; at pH 8.3, the peak is at 355 mu 
(AA/A = 1.0 X 10~^) with a small negative peak in the 395 to 425 mp 
region and, at pH 5.4, a peak at 440 my appeared (AA/A = 2.0 x 10' ). 
Figure 15. Absorption spectra of apoGOT-III—a-ketoglutarate complex 
in 0.1 M acetate, pH 5.4, and in 0.01 M triethanolamine 
HCl, pH 8.3. The absorbance at 510 mu (0.46) was sub­
tracted from the pH 5.4 spectrum as a partial correction 
for turbidity. Concentrations of a-ketgglutarate. III, 
and protein are 
respectively 
-
5.0 X 10-3 10 X 10-4 M, and 9.3 x lO'S M 
Figure 16. CD spectra of apoGOT-III—a-ketoglutarate complex in 0.1 
M acetate, pH 5.4, and in 0.01 M triethanolamine HCl, 
pH 8.3. At pH 8.3, AA/A = 7.1 x lO"* at 372 my. 
Concentrations are the same as Figure 15 
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Figure 17. Absorption spectra of apoGOT-IV in 0.1 M acetate, pK 5.4, 
and in 0.01 M triethanolamine HCl pH 8.3, (solid lines); 
and of IV in 0.01 M triethanolamine HCl, pH 8.3, (broken 
line). Concentrations of IV and protein are 1.0 x 10"^ M 
and 9.3 X 10"^ M respectively 
Figure 18. CD spectra of apoGOT-IV in 0.1 M acetate, pH 5.4, and in 
0.1 M triethanolamine HCl, pH 8.3. At pH 5.4 
AA/A = 2.0 X 10"^ at 440 my; at pH 8.3, AA/A = 1,0 x 10"^ 
at 335 mu. Concentrations are the same as Figure 17 
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Using 6.0 x 10"^ M IV and 5.3 x 10"^ M apoGOT the above absorption 
data were confirmed in a second experiment at pH 8.3, but in a third 
preparation of apoGOT-IV (also at 6.0 x 10"5 m) an additional absorption 
maximum at 330 my was obtained. This preparation utilized apoGOT 
that had not been freshly prepared. 
Like the case of III, IV could be displaced from the protein by 
PLP and the rate constant, k|, of the dissociation of IV from apoGOT-
IV in the presence of an excess of PLP (see page 31 for method) was 
evaluated. From the slope of a first order plot (Figure 19), a value 
of 3.44 x 10"^ sec"^ was calculated which gave a half-life, ty2 of 
33 minutes for the dissociation. 
Reaction with substrates 
With L-aspartate and a-ketoglutarate (20 ymoles each, 200 umoles 
Tris, pH 8.3; volume 3 ml) apoGOT-IV showed about the same amount of 
catalytic activity as that of apoGOT-flI; at 5,5 x 10"^ M the activity 
of apoGOT-IV was 0.10 mM/min/mg which is 0.24% of the activity 
(41.0 ntfl/min/mg) of apoGOT-PLP at a concentration of 5.5 x 10"^ M. The 
same activity was exhibited by a second preparation of apoGOT-IV. 
The addition of 0.1 ml of 0.2 M L-glutamate to 1.0 ml of 6.0 x 10'^ M 
apoGOT-IV in a cuvette caused a rapid decrease in the absorption at 359 mp 
and the appearance of a peak at 325 my (Figure 20), An absorption peak 
at 430 my initially appeared (maximum absorbance occurred at about two 
minutes after addition of L-glutamate) and then slowly decreased; as the 
430 my absorption declined, the absorbance at 325 my increased. The 
absorption changes ceased in 40 minutes; at this point 0.1 ml of 0,1 M 
Figure 19. First order plot of reactivation of apoGOT-IV by an excess 
of PLP. V^, the initial velocity at time t in absorbance 
units/sec., minus V„» the initial velocity at equilibrium, 
is plotted on a login scale. Concentrations of IV, PLP, and 
protein are 1.0 x 10-6 M, 2.5 x 10" M, and 914 x 10"' M 
respectively 
Figure 20. Absorption spectra of apoGOT-IV after reaction with 
L-glutamate. 
apoGOT-IV (no substrate! 
apoGOT-IV in 1.82 x 10"^ M L-glutamate (2 minutes) 
apoGOT-IV in 1.82 x 10"^ M L-glutamate (15 minutes) 
Concentration of IV is 6.0 x 10" M. Protein concentration 
is 5.3 x 10"5 M. All solutions are in 0.01 M triethanolamine 
HCl, pH 8.3 
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a-ketoglutarate, pH 4,8, was added which caused no initial change in 
the absorption spectrum. After 21 hours at room temperature» the absorp­
tion at 430 mu had increased very slightly (0.05 absorbance units) 
while the absorption at 325 mu had decreased by half as much (0.03). 
The final pH of the solution was 6.5. The preparation of apoGOT-IV 
with an absorption peak at 330 mu exhibited this same behavior toward 
L-glutamate. 
In 1.82 x lOT^ M L-glutamate, IV at concentration of 9.0 x 10"^ M 
exhibited two absorption maxima in 0.01 M triethanolamine HCl, pH 8.3; 
one at 419 mu (e= 3.7 mM~^ cm~^) and the other at 292 mu (e= 5.8 mM~^ 
cm~^). 
V Methyl Phosphonic Acid 
of Pyridoxal Phosphate 
Binding 
ApoGOT (9.3 x 10"^ M) was combined with V (1.0 x 10"^ M) in 0.01 
M triethanolamine HCl, pH 8.3. The bound V exhibited an absorption 
peak at 370 mu, a change of 20 mu from the absorption maximum of the 
unbound V, (Figure 21) and a CD spectrum with a maximum at 365 mu 
(aA/A = 1.5 x 10"^) as shown in Figure 22. Lowering the pH of the solution 
to 5.4 by addition of 1.0 M acetate (final concentration was 0.1 M) 
did not change the absorption or CD spectra. (6.0 x 10"^ M V and 
5.3 X 10'^ M apoGOT) gave a much higher absorbance at 370 mu then 
expected (relative to its concentration) as shown in Figure 24. The 
reason for this discrepancy Is not known but It is assumed to be the 
Figure 21. Absorption spectra of apoGOT-V and V in 0.01 M triethanolamine 
HCl, pH 8.3, Concentration of V is 1.0 x 10"^ M. Protein 
concentration is 9.3 x 10"^ M 
Figure 22, CD spectrum of apoGOT-V in 0.01 M triethanolamine HCl, 
pH 8.3. aA/A = 1.5 x 10" at 365 my. Concentrations are 
the same as Figure 21 
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Figure 23. First order plot of reactivation of apoGOT-V by an excess 
of PLP. the initial velocity at time t in absorbance 
units/sec., minus V», the initial velocity at equilibrium, 
is plotted on a logig scale. Concentrations of V, PLP, and 
protein are 1.0 x 1(J~& M, 2.5 x 10"^ M, and 9.4 x 10"' M 
respectively 
Figure 24. Absorption spectra of apoGOT-V after reaction with substrates. 
apoGOT-V, pH 8.3 (no substrate) 
apoGOT-V in 1.82 x 10" M L-glutamate, pH 8.3, 
(2 minutes) _ 
apoGOT-V in 1.82 x 10" M L-glutamate, pH 8.3, 
(20 minutes) o , 
^apoGOT-V in 1.66 x 10" M L-glutamate and 8.3 x 10" M 
a-ketoglutarate, pH 6^5 
Concentration of V is 6.0 x 10"^ M. Protein concentration 
is 5.3 x 10"^ M. All pH 8.3 solutions are in 0.01 M 
triethanolamine HCl 
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result of an experimental error. In this second preparation the 370 mu 
absorption was 94% complete within 3 minutes after mixing and the maximum 
absorbance occurred after 15 minutes; during this time the absorbance 
in the 400 to 430 mu region decreased. 
Since V could be displaced from apoGOT-V by PLP, the rate constant, 
k-j, of the dissociation of apoGOT-V was determined in the same manner 
as were III and IV (see page 31 for method). The first order plot 
shown in Figure 23 gave a value of 5.04 x 10"^ sec"^ for k-j and a 
half-life, t^^g* of 23 minutes for the dissociation. 
Reaction with substrate 
With L-aspartate and a-ketoglutarate (20 ymoles each, 200 umoles 
Tris, pH 8.3; volume 3 ml.) apoGOT-V showed a small amount of enzymic 
activity; at 5.5 x 10"^ M the activity was 0.056 mM/min/mg which is 
0.14% of the activity (41.0 mM/min/mg) of apoGOT-PLP at a concentration 
of 5.5 X IGT? M. 
The addition of 0.1 ml of 0.2 M L-glutamate, pH 8.3, to 1.0 ml 
of 6.0 x 10"^ M apoGOT-V in a cuvette resulted in the conversion of the 
370 my species to a form absorbing at 315 my (Figure 24). After 2 
minutes 35% of the 370 my absorption remained which subsequently 
decreased to 14% during an 18 minute period (see Figure 24) and ceased. 
At this point 0.1 ml of 0.1 M a-k ^jglutarate, pH 4.8, was added; the 
absorption maximum was rapidly changed to 327 my and a small increase 
at 370 my was noted. The absorption at 370 my increased at a very slow 
rate (about 0.01 absorbance units in 30 minutes). The final pH of the 
solution was 6.5. 
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V (9.0 x 10"^ M) in 1.82 x 10"^ M L-glutamate exhibited two 
absorption maxima in 0.01 M triethanolamine HCl, pH 8.3: 
405 mu (E= 3.85 cm~^) and 278 mu (e= 4.0 cm~^). 
VI Cyanoethyl Ester of 
Pyridoxal Phosphate 
Binding 
ApoGOT (9.3 x 10'^ M) and VI (1.0 x 10"^ M) were allowed to react 
in 0.01 M triethanolamine HCl, pH 8.3; a shift of 20 mu from the absorbance 
maximum of the free compound (390 mu) to 370 mu was observed (Figure 25). 
1.0 M acetate, pH 5.4, when added to a final concentration of 0.1 M, 
caused an increase in absorption in the 430 mu region and also resulted 
in the complex becoming unstable. The corresponding CD spectra 
(Figure to) showed a single peak at 369 mji (M/A = 1.3 x 10"^) at pH 8.3; 
at pH 5.4, a low broad peak in the 430 mu region appeared while the major 
CD peak shifted slightly to 363 mu. A second preparation of apoGOT-VI 
(6.0 x 10"^ M VI and 5.3 x 10"^ M apoGOT) exhibited a higher absorbance 
at 370 my than expected for its concentration (see Figure 28); the same 
observation that occurred with a preparation of apoGOT-V. In this 
second preparation the absorption at 370 mu was about 67% complete 2 
minutes after mixing, with the remainder being added over a 20 minute 
period. As the absorption at 370 mu increased, the absorbance in the 390 
mu to 430 mu region decreased. 
Figure 25. Absorption spectra of apoGOT-VI in 0.1 M acetate, pH 5.4, 
and in 0.01 M triethanolamine HCl, pH 8.3 (solid lines); 
and of VI in 0.01 M triethanolamine HCl, pH 8.3, (broken 
line). Concentrations of VI and protein are 1.0 x 10~^ M 
and 9.3 x 10"^  M respectively 
Figure 26. CD spectra of apoGOT-VI in 0.1 M acetate, pH 5.4, and in 
0.01 M triethanolamine HCl, pH 8.3. At pH 8.3, 
aA/A = 1.3 x 10"3 at 369 my. Concentrations are the same 
as Figure 25 
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Figure 27. First order plot of reactivation of apoGOT-VI (no PLP added). 
V^, the initial velocity at time t in absorbance units/min., 
minus the initial velocity of apoGOT-PLP at the same 
concentrations, is plotted on a login scale. Concentrations 
of VI and protein are 1.0 x 10"" M and 9.4 x lOT' M 
respectively 
Figure 28. Absorption spectra of apoGOT-VI after reaction with substrates 
apoGOT-VI, pH 8.3 (no substrate) 
. apoGOT-VI in 1.82 x 10"% M L-glutamate, pH 8.3, 
(2 minutes) 
apoGOT-VI in 1.82 x 10"^ M L-glutamate, pH 8.3, 
(30 minutes) 
apoGOT-VI in 1.66 x 10"^ M L-glutamate and 8.3 x 10"^ 
M a-ketoglutarate, pH 6.4, (60 minutes after 
addition of a-ketoglutacate) 
Concentratiop of VI is 6.0 x 10"^ M. Protein concentration 
is 5.3 x 10"^ M. All pH 8.3 solutions are in 0.01 M 
triethanolamine HCl 
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Reaction with substrate 
Assays of apoGOT-VI gave unexpected results; the activity of the 
complex increased with time as shown in Table 4. 
Table 4« Reactivation of apoGOT-VI 
Time 
(mi nutes) 
Activity® 
(mM/min) 
5 0.0040 
55 0.0180 
120 0.0314 
140 0.0354 
185 0.0401 
245 0.0456 
290 0.0480 
320 0.0490 
^20 umoles L-glutamate, 2 utnoles oxaloacetate, 200 umoles Tris, pH 
8.3; volume 3 ml. 0.0035 mg of apoGOT-VI used for each assay. 
Using the activity of PLP-reactivated apoGOT of the same concentration as 
a value of Va,, the data in Table 4 gave a straight line on a first order 
plot (Figure 27). From this plot the value of the rate constant was 
calculated as 1.3 x 10"^ sec"^ which is equivalent to a half-life of 
88 minutes for the reactivation. 
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VI does not display this self-reactivating behavior when bound to 
1 2 
either L-glutamic acid decarboxylase or to glycogen phosphorylase b_ . 
A spectral examination of apoGOT-VTs behavior toward substrate 
was performed. 0.1 ml of 0.2 M L-glutamate, pH 8.3, was added to 1.0 ml 
of 6.0 X 10"^ M apoGOT-VI in 0.01 M triethanolamine HCl, pH 8.3, 
about 20 minutes after VI was mixed with apoGOT. The addition of 
L-glutamate caused a slow decrease in the 370 mu absorption (Figure 28) 
and the appearance of a shoulder at about 317 mu. About 30 minutes 
were required for the absorbance changes to cease; at this point 0.1 
ml of 0.1 M a-ketoglutarate, pH 4.8, was added. The a-ketoglutarate 
caused an immediate formation of a peak at 326 mu (see Figure 28) and 
the absorption along a plateau from 370 mu to 450 mu was very slowly 
increased. The final pH of the solution was 6.4. 
VI (9.0 x 10"^ M) in 1.82 x 10'^ M L-glutamate has (in 0.01 M 
triethanolamine HCl, pH 8.3) two absorption maxima: 
399 mu (e= 2.5 mM"^ cm"^) and 284 mu (e= 3.2 mM~^ cm~^). 
^Dr. Margaret L. Fonda, Ames, Iowa, Iowa State University of Science 
and Technology, Department of Biochemistry and Biophysics. Private 
communication. 1968. 
2 
George F. Johnson, Ames, Iowa, Iowa State University of Science 
and Technology, Department of Biochemistry and Biophysics. Private 
communication. 1968. 
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VII and VIII Pyridoxal 
and Deoxypyn" doxal 
Pyridoxal (VII) predominately exists in acidic, neutral, and 
alkaline solutions as a hemiacetal (Vila); although the proportion of 
free aldehyde increases at high pH (Martel!, 1963). The absorption 
band at 390 mu which is assigned to the dipolar carbonyl form is very 
weak, while the band assigned to the dipolar hemiacetal form (at 317 
mji) is quite intense. VII at a concentration of 1.0 x 10"^ M was 
combined with apoGOT (9.3 x 10"^ M) ; absorbance in the region above 
350 mu increased only slightly, and possessed no enzymic activity. 
Therefore, VII was not utilized for further study. 
Deoxypyridoxal (VIII) at a concentration of 5.0 x 10"^ M was 
allowed to combine with apoGOT (1.1 x 10"^ M) which had been prepared 
from cytoplasmic GOT (subforms not separated). The CD of this solution 
showed two peaks of very low intensity: one in the 350 to 375 mu 
region (maximum CD =-1.9 (+0.5) x 10"^). The solution was dialyzed 
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against buffer for one hour; the CD band above 400 mu was reduced 
approximately in half (maximum CD = 0.7 0.5) x 10"*) while the CD 
below 400 mu remained the same. Dialysis was not complete as the 
absorption spectrum exhibited free VIII. Of interest is the fact that 
the CD above 400 mu was reduced during a short period of dialysis while 
CD below 400 mu is not and that the intensity of apoGOT-VIII's CD is 
very low. 
VIII (6.25 x 10"^ M) was combined with apoGOT (9.0 x 10 ^  M; 
prepared from a-GOT); in 20 minutes the absorption maximum shifted 
from 390 mu (the maximum for the free compound) to 380 my (Figure 29)^. 
Also the absorption around 430 mu was quite high relative to that of 
the unbound compound. Addition of 0.1 ml of 0.2 M L-glutamate (total 
volume was then 0.9 ml) resulted In the disappearance of the 380 mu 
peak and the formation of a peak at 320 mu. Absorption about 425 mu 
reduced more slowly than that at 380 mu. The absorbance changes 
ceased in 4 minutes. 0.1 ml of 0.1 M a-ketoglutarate was then added; 
the absorbance in the 375 mu region increased very slowly (about 0.02 
in 10 minutes). 
All experiments with VII and VIII were done in 0.01 M triethanol-
amine HCl, pH 8.3. 
This experiment was performed by Dr. Margaret L. Fonda of the 
Department of Biochemistry and Biophysics, Iowa State University, Ames, 
Iowa. 
Figure 29. Absorption spectra of VIII and of apoGOT-VIII before and 
after reaction with L-glutamate. 
—apoGOT-VIII (no substrate! 
apoGOT-VIII in 2.22 x 10" M L-glutamate (10 minutes) 
VIII c 
Concentration of VIII is 6.25 x 10" M. Protein concentra­
tion is 9.0 x lo'S M. All solutions are in 0.01 M tri-
ethanolamine HCl, pH 8.3 
Figure 30. Absorption spectra of apoGOT-IX in 0.1 M acetate, pH 5.4, 
and in 0.01 M triethanolamine HCl, pH 8.3, (sol4d lines); 
and of IX in 0.01 M triethanolamine HCl, pH 8.3, (broken 
lines). Concentration of IX is 1.0 x 10"* M. Protein 
concentration Is 9.3 x 10"^ M 
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IX N-Methyl Pryidroxal Phosphate 
Binding 
IX (1.0 X 10"4 M) was combined with 9.3 x 10"^ M apoGOT in 0.01 
M triethanolamine HCl, pH 8.3; the absorption maximum was shifted 
about 20 mu (from 398 mu to 377 my) after binding (Figure 30). An 
additional maximum was formed at 425 mu upon addition of 1,0 M acetate, 
pH 5.4, to a final concentration of 0.1 M in acetate. The CD spectra 
also exhibited pH-dependent behavior (at 375 mu, aA/A = 2.0 x 10"^ at 
both pH values) as shown in Figure 31. The absorption characteristics 
of apoGOT-IX at pH 8.3 was confirmed in a second preparation using 
concentrations of 6.0 x 10~^ M IX and 5.3 x 10"^ M apo-GOT (see Figure 
32). This latter preparation was utilized for activity studies. 
Reaction with substrate 
The addition of 0.1 ml of 0.2 M L-glutamate, pH 8.3, to 6.0 x 10'^ M 
apoGOT-IX caused the slow reduction of the 377 mu peak and the formation 
of a maximum at 335 my (Figure 32). After 25 minutes the 377 mu 
peak was reduced by only 40%. The solution was incubated overnight 
at room temperature and 0.1 ml of 0.1 M a-ketoglutarate, pH 4.8, was 
added. The a-ketoglutarate, did not cause any change in the absorption 
during a 15 minute period. The final pH of the solution was 6.4. 
At 5.5 x 10'^ M, apoGOT-IX showed a very small amount of enzymic 
activity (0.05 mM/min/mg) with L-aspartate and a-ketoglutarate (20 umoles 
each, 200 umoles Tris, pH 8.3; volume 3 ml). This activity is only 
0.12% of the activity of apoGOT-PLP at 5.5 x 10"^ M. The low activity was 
Figure 31. CD spectra of apoGOT-IX in 0.1 M acetate» pH 5.4, and in 
0.01 M tri ethanol ami ne HCl» pH 8.3. At 377 mu, WA 
= 2.0 X 10""^ at both pH 5.4 and 8.3. Concentrations are 
the same as Figure 32 
Figure 32. Absorption spectra of apoGOT-IX after reaction with 
L-glutamate. 
apoGOT-IX (no substrate) 
apoGOT-IX in 1.82 x 10"| M L-glutamate (2 minutes) 
-apoGOT-IX in 1.82 x 10"^ M L-glutamate (25 minutes) 
Concentration of IX is 6.0 x 10"^ M. Protein concentration 
is 5.3 x lo'S M. All solutions are in 0.01 M triethanol-
amine HCl, pH 8.3 
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confirmed by another preparation of apo60T-IX. 
Addition of L-glutamate to IX did not cause any change in the 
absorption behavior of IX. 
X Pyridoxal Phosphate N-oxide 
Binding and reaction with substrate 
X at a concentration of 6.0 x M was combined with apoGOT 
(5.3 X 10"^ M) in 0.01 M triethanolamine, HCl pH 8.3. The binding 
caused a reduction in the absorption maximum (392 my) of the free X 
and the formation of a broad band from 375 mu to 410 mu (Figure 33). 
The absorption at 430 mu was increased and a shoulder at 320 mu 
was present. 
The addition of 0.1 ml of 0.2 M L-glutamate, pH 8.3, (total 
volume was then 1.1 ml) caused the rapid destruction of the absorbance 
above 350 mu except for a slower reduction at 425 mu (Figure 34). 
Also, a definite peak at 325 mu was formed. The absorption changes 
stopped in about 14 minutes. At this point, 0.1 ml of a-ketoglutarate, 
pH 4.8, was added; a peak was quite rapidly formed at 425 mu which 
slowly increased during the next hour (see Figure 34). In addition, 
a-ketoglutarate caused a slight reduction in absorbance at 325 mu and a 
shift to 320 mu. The final pH of the solution was 6.6. 
At 5.5 X 10"^ M, apoGOT-X had an activity of 12.6 mM/min/mg in 
L-aspartate and a-ketoglutarate (20 umoles each, 200 umoles Tris, pH 8.3; 
volume 3 ml) which is 31% of the activity possessed by apoGOT-PLP at this 
concentration. 
Figure 33. Absorption spectra of apoGOT-X (solid line) and of X (broken 
line) in 0.01 M triethanolamine HCl, pH 8,3. Concentration 
of X is 6.0 X 10"5 M. Protein concentration is 5.3 x 10"^ 
M 
Figure 34. Absorption spectra of apoGOT-X after reaction with L-
glutamate. 
apoGOT-X in 1.82 x IQ-Z M L-glutamate, pH 8.3 
(2 minutes) 
apoGOT-X in 1.82 x lOT^ M L-glutamate, pH 8.3 
(14 minutes) « 
apoGOT-X in 1.66 x 10 M L-glutamate and 8.3 
X 10"3 M a-ketoglutarate, pH 6.5 (2 minutes) 
^apoGOT-X in 1.66 x 10"^ m L-glutamate and 8.3 
X 10"^ M a-ketoglutarate, pH 6.5 (75 minutes) 
Concentrations of X and protein are the same as Figure 33. 
All pH 8.3 solutions are in 0.01 M triethanolamine HCl 
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These results are in agreement with those of Ohishi, et al. 
(1968) who also reported that apoGQT-X exhibited CD at 420 MU (AA/A 
= 1.3 x 10"^  at pH 5.0) and that the absorption at 420 mu is pH 
dependent. 
X in the presence of L-glutamate shows a slight shift to 396 mu. 
Summary of Results 
Spectral data of the various cofactors are summarized in Table 
5 and their activities with apoGOT in Table 6. 
Table 5. Summary of spectral data of compounds I -
Wavelength of maximum absorbance/CD, my 
Compound Free compound Bound to apoGOT 
pH 8.3 pH 8.3 pH 5.4 With L-glutamate With L-glutamate 
and a-ketoglutarate 
I 390 
364/362 
(2.0 X 10-3) 
430/430^ 
(3.2 X lO'S) 
332/330 
(1.5 X 10"^) 
III 390 
368/362 
(1.6 X 10"3) 
same as 
pH 8.3 
320 323 
IV 
369 
325 
359/355C 
420/415 
(1.0 X 10-3) 
430/440 
(%.0 X 10"3) 
325^ 325 
V 390 
370/365 
(1.5 X 10"3) 
same as 
pH 8.3 
315 327 
CD maxima are shown following the absorbance maxima and are separated by a diagonal line (/). 
The values of AA/A are given in parenthesis. Compound II is not included because of its 
similarity with I. Compound VII is not included because of its lack of binding as a 
hemiacetal. 
^Data obtained at pH 4.8. 
^The single preparation of apoGOT-IV showing a 330 mw peak Is not included. 
d 
In addition, an intermediate absorbing at 430 my was observed. 
Table 5 (Continued) 
Compound Free compound 
pH 8.3 pH 8.3 pH 5.4 With L-glutamate With L-glutamate 
and g-ketoqlutarate 
VI 370/369 
(1.3 x 10"3) 
same as® 
pH 8.3 
317 326 
VIII 391 380/~365 
(~2 X 10-4) 
-
320 320 
IX 398 
377/375 
(2.0 x 10-3) 
425/430 
(2.4 x 10-3) 
335 335 
X 392 
380-405/ 
320/ 
~420/420F 
(1.3 X 10-3) 
325 
320 
425 
®With the exception of the species absorbing at 430 mw which is thought to be PLP (see 
Discussion). 
f Source: Qhishi, et , 1968. Data obtained at pH 5. 
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Table 6. Reactions of apoGOT-bound cofactors with substrates 
Kisiy ~ 
Compound Reaction with Reaction with activity 
L-g1utamate^ a-ketoglutarate^ (mM/min/mg) 
I 364 tnu to 332 mu 
(«2 minutes) 
III 370 mp to 320 mu 
( minutes) 
412 mu to 320 mu 
(~20 minutes) 
IV 359 mu to 325 mu 
(<2 minutes) 
359 mu to 430 mu 
(^2 minutes) 
430 mu to 325 mu 
(slow) 
V 370 mu to 315 mu 
(>2 minutes) 
VI 370 mu to 317 mu 
(>20 minutes) 
VIII 380 mu to 320 mu 
(~2 minutes) 
425 mu to 320 mu 
(~4 minutes) 
IX 377 mu to 335 mu 
(>20 minutes) 
X 380-405 mu to 325 mu 
(<2 minutes) 
425 mu to 325 mu 
(<20 minutes) 
332 mu to 364 mu 
(«2 minutes) 
320 mu to 323 mu 
(<2 minutes) 
323 mu to 375 mu 
(slow) 
325 mu to 430 mu 
(very slow) 
315 mu to 327 mu 
(<2 minutes) 
327 mu to 370 mu 
(very slow) 
317 mu to 326 mu 
(>2 minutes) 
326 mu to 370 mu 
(very slow) 
320 mu to 375 mu 
(very slow) 
335 mu to 377 mu 
(very slow) 
325 mu to 320 mu 
(< 2 minutes) 
320 mu to 425 mu 
(~2 minutes) 
41.0 
0.095 
0.10 
0.056 
varying^ 
0.05 
12.6 
For reaction conditions, see text of Results. 
^20 umoles each of L-aspartate and a-ketoglutarate, 200 umoles of 
Tris, pH 8.3; volume 3 ml. 
^Activity increased with age of preparation. 
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DISCUSSION 
Analogs with varied substituants in the 5'-position will be 
considered with regard to their binding to apoGOT and their subsequent 
reactions with substrate before the pyridine ring nitrogen substituents 
are discussed. 
5'-Analogs (III-VIII) 
Binding characteristics 
With the exception of VII (pyridoxal), all of the 5'-analogs 
are bound by apoGOT. In the case of VII, the lack of activity and the 
absence of absorption in the 360 to 380 my region may be ascribed to the 
non-availability of a free 4'-aldehyde group resulting from hemiacetal 
formation. While it cannot be claimed that the hemiacetal does not 
bind to apoGOT at all, the uselessness of VII as a coenzyme is apparent. 
At substrate-levels of concentration, however, VII can be transaminated 
into pyridoxamine by apoGOT (Wada and Snell, 1962) at less than 0.1% 
of the rate of normal transamination. The ease of dissociation of 
pyridoxamine (which, of course, cannot be in a hemiacetal configuration) 
from the enzyme reported by these authors demonstrates the small 
contribution of the 5'-hydroxy group to the compound's binding ability. 
Interestingly, this transamination was inhibited by inorganic phosphate, 
which presumably acted by occupying the site normally occupied by the 
5'-phosphate of PLP and preventing pyridoxal or pyridoxamine from binding. 
The evidence for the binding of the remaining 5'-analogs (III-VI, 
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VIII) to apoGOT is conclusive: all demonstrated a characteristic 
hypsochromic shift of 10 to 25 mu from the electronic absorption maxima 
of the free compounds, all were rigidly located in an asymmetric 
environment as shown by their circular dichroism, and all showed some 
enzymic activity (although poorly). The optical properties of the bound 
cofactors are interesting. Like PUP, these analogs exhibited a decrease 
in the wavelengths of their absorption maxima upon binding as imines 
at the active site of GOT (10-11 mn for IV and VIII; 20-26 mp for PLP, 
III, V, and VI). In addition, at pH 8.3 the absorption spectra of all 
cofactors showed the presence of a species absorbing in the 410 to 430 mu 
region. Except for analog VIII (deoxypyridoxal), the absorption above 
400 mu decreased as the maxima in the 370 my region increased. This was 
particularly evident for those analogs which bound more slowly to the 
protein (V and VI). It is proposed that the absorption above 400 my 
results from a non-specific binding of the cofactors to the protein; 
that is, the analogs may bind to sites other than the active site before 
binding to the active site. Martinez-Carrion and coworkers (1967) 
reported twenty lysyl residues present in the protein per mole of PLP; 
consequently, there should be several sites available for Schiff base 
formation between the protein and the coenzyme. Rearrangement of the co-
factor from the easily-attacked non-specific sites to the active site 
would give the observed absorption changes. An alternative explanation 
may be advanced: the binding of the cofactors may occur at the active 
site, but in such a manner as to give rise to absorption maxima above 
400 my. The bound cofactors may then rearrange to a conformation giving 
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absorption maxima about 370 mu without leaving this site. Either case 
may be considered as a non-specific binding since PLP bound in an 
enzymically active configuration at the active site has an absorption 
maximum at 354 mu. Further evidence for the existence of non-specific 
binding (without regard to which site is occupied) is given by the 
higher > 400 mu absorption of apoGOT-PLP relative to that of the native 
enzyme, and it is known that an excess of PLP inhibits GOT's activity. 
Thus, PLP can bind to the protein in modes other than the active one; 
it is reasonable to think that the other cofactors can also. 
The situation with VIII was the reverse of the above binding 
behavior: the absorption at 430 mu increased while the maximum at 380 mu 
decreased. This behavior of apoGOT-VIII would seem to indicate that VIII 
has a slightly higher affinity for a non-specific type of binding than 
for the active mode; however, the CD data do not confirm this conclusion 
(discussed below). 
A further consequence of binding by these analogs (III-VI, VIII) 
was the appearance of a Cotton effect at their major absorbing fre­
quencies. While small in magnitude, the circular dichroism exhibited by 
the bound analogs existed and was easily measurable. Since the unbound 
analogs are optically inactive, and become optically active upon 
binding, the rotational strength is a measure of these chromophores' 
interaction with their asymmetric environments. In other words, an 
averaging out of the configurations of the analog through free rotation is 
prevented by steric restraint. In addition, the rotational strength 
reflects the asymmetry induced in the electron distribution within the 
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chomophore. Thus, the rotational strength of a bound cofactor is 
dependent upon the steric hinderance imposed by the protein and upon 
the charge perturbation of the chromophore. 
In this study, CD results are reported as the ration of observed 
CD (aA) to the normal absorption (A). Since the observed CD and the 
absorption were measured on the same sample with equal path length 
e. -E 
(1 cm.), then aA/A is equal to ——- , where and are the molar 
extinction coefficients for left- and right-handed circularly polarized 
light respectively and e is the usual molar extinction coefficient. 
This value is equivalent to the dissymmetry factor (or anistropy factor) 
of Kuhn (1958). Although "the anisotropy factor of a given absorption 
band is a unique function of the spatial and angular distribution of 
the corresponding vibrating momentum" (Kuhn, 1958, p. 425), it is not 
utilized here in any theoretical sense. CD results are reported as 
aA/A because this value provides a convenient means of expressing CD 
that is independent of concentration and, hence, gives a method for 
comparing the amount of CD shown by the different cofactors. CD 
measurements were made on the apoGOT-cofactors to demonstrate unequivo­
cally that the analogs were bound. At best, values for the observed 
CD can be used only as an indication of asymmetry produced by binding. 
With reference to the values reported for aA/A, It should be noted 
that aA and A values were taken at the peak position of the CD spectra 
in those cases where the absorption and CD maxima did not occur at the 
same wavelength. While most CD and absorption spectra were quite closely 
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aligned, some were not. Furthermore, aA/A values are not constant over 
the total transition band contrary to previous claims for single 
transitions (Kuhn, 1958). This anomaly frequently occurs and the 
usual explanation offered assumes the existence of two electronic 
transitions which overlap, and that one of these transitions is 
optically inactive (Velluz^^., 1965, p. 206). This explanation 
seems reasonable for the case of a protein-bound cofactor where the 
absorption band may consist of several vibrational transitions. 
The observed aA/A values, at pH 8.3, ranged from ~2 x 10"^ for PLP. 
With the exception of apoGOT-VIII, all of the bound cofactors possessed 
moderately high amounts of CD at their major absorption peaks (see 
Figures 3, 6, 9, 18, 22, and 26). When bound to apoGOT analogs III 
(carboxymethyl-deoxypyridoxal) and IV (deoxypyridoxalyl phosphonic 
acid) exhibit a small amount of negative CD above 400 mp (Figures 9 
and 18). THis is thought to arise from a non-specific type of binding 
at a site where asymmetry is imposed. 
With regard to non-specific types of binding, the experiment 
illustrated in Figure 10 is pertinent. ApoGOT-III was reduced with 
sodium borohydride; as with PLP after reduction, the absorption and CD 
maxima shifted to 332 rap (Figure 10a). Addition of a ten-fold excess 
of PLP (followed by dialysis to remove the free PLP) destroyed the CD 
at 332 my and established a small negative CD peak at 414 mji; the 
absorption spectrum showed maxima at 390 and 325 mu (Figure 10b). While 
the absorption of the apoGOT-III reduced complex remained, the asymmetry 
of its site was destroyed by PLP in the same region. Since the absorption 
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maximum at 390 mu is characteristic of free PLP, it is possible that 
the PLP is bound by noncovalent interaction and not by imine formation. 
After reduction of the PLP-reduced apoGOT-III complex, the absorption 
and CD maxima were at 329 mu (Figure 10c). This result would be 
obtained if PLP was bound covalently as an imine and reduced to a 
secondary amine; or if bound noncovalently, PLP would be reduced to the 
alcohol, pyridoxol phosphate, which absorbs at 330 mu. The latter 
possibility does not explain the appearance of CD at 329 mu, since it 
is hard to see why the reduction of a free aldehyde group to a free 
hydroxy1 group would induce asymmetry. However, it is quite possible 
that the pyridoxol phosphate is removed during the borohydride 
reduction, which would restore the asymmetry of the site. At this 
point, it is not known which kind of binding is involved. 
An experiment conducted with apoGOT-VIII with excess VIII present 
had two peaks of very low intensity with one peak located below 400 mu 
and the other above. A short (and not complete dialysis reduced the 
CD above 400 mu. Since the dialysis was very gentle (no dilution of 
protein occurred), the asytmnetry of the binding should not be affected; 
therefore, the reduced CD above 400 mu reflects the ease of dissociation 
of VIII from this type of binding as contrasted with the binding which 
absorbs in the 370 mu region. This result contradicts the binding 
characteristics of VIII as shown by an absorption change fran 380 mu 
to 430 mu (discussed above). It should be noted that two different 
apoGOT preparations were used; the subforms were not separated in the 
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preparation utilized tor the CD experiment and the additional non­
specific binding of VIII with apo-a-GOT may just occur with this sub-
form. In either case, VIII does not seem to bind as rigidly as do the 
other analogs» and it shows a higher tendency toward non-specific 
binding. 
Examination of the effect of pH upon the behavior of the absorption 
and CD spectra of the bound analogs, III-VI, yielded two unexpected 
and important conclusions. Only IV showed a pH dependence similar to 
that of PLP in the pH range of 5.4 to 8.3 while III, V (the methyl 
phosphonic acid of PLP), and VI (the cyanoethyl ester of PLP) did not. 
Therefore, the pH dependent spectral shift is subject to the presence 
of two negative charges (or at least the potential of two negative 
charges by ionization) on the 5'-substituent. Furthermore, in order to 
influence the pK of the imine nitrogen in such a manner, the 5'-substituent 
must fold back and lie over the pyridine ring. The small amount of 
absorption at 430 my (pH 5.4) shown by VI (Figure 26) is thought to be 
caused by PLP (see below). 
Information regarding the relative ease of dissociation of III, IV, 
and V from apoGOT was obtained by reactivating apoGOT-III, -IV, and -V 
with PLP in excess (Figures 12, 19, and 23). The half-lives of the 
dissociation of III, IV, and V were 41, 34, and 23 minutes respectively. 
That the methyl phosphonic acid derivative is the most easily dissociated 
is not surprising since it is the most bulky of the three analogs. 
To be sure, more steric hindrance is imposed upon IV than III; that is. 
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there are fewer conformations allowed for IV, but it was thought 
that the ionic attraction between the protein and 5'-substituent would 
be greater for IV than for III. Nevertheless, III is bound more firmly 
than IV. The rates of binding of these cofactors parallel this series: 
III and IV are bound (as shown by absorption changes) within two minutes, 
while V requires a short while longer. Data obtained from reactivating 
apoGOT-III with a stoichiometric amount of PLP (Figure 11), while 
subject to error, gives a value for Ill's affinity for apoGOT as about 
20% that of PLP. 
The longer time required by VI for binding to apoGOT (about twenty 
minutes) demonstrates the difficulty of inserting a bulky cyanoethyl 
group into the binding site. 
In brief, these analogs show that the spatial arrangement and the 
charge distribution of the 5'-substituent is of crucial importance in 
binding to the active site of GOP. 
Reaction with substrates 
Assays of the bound 5'-substituent cofactors did not provide much 
information as to their reaction characteristics with substrates except 
to demonstrate their poor catalytic abilities. By examining their 
behavior with substrates at spectroscopic levels of concentration, 
however, a somewhat clearer picture emerges. 
ApoGOT-III reacts quite rapidly with L-glutamate as shewn by a 
decrease in the absorption at 370 my and the appearance of the amine form 
which absorbs at 320 mp (Figure 13). The absorption resulting from non­
specific binding (at about 412 my) decreased also, but more slowly than 
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the major peak. The reaction with L-glutamate by the non-specifically 
bound form is interesting and three possible situations exist: a) 
the non-specific binding of III occurs at the active site, and the 
formation of a substrate-analog imine forces this aldimine inter­
mediate into a conformation favorable for catalytic action by the 
enzyme; b) the non-specific binding of III occurs at a site other than 
the active site, and for catalysis to take place, the cofactor is 
removed from this site by Schiff base formation with the amino acid and 
is then bound at the active site either by binding as the substrate 
aldimine or by transaldimination with the e-amino group at the active 
site; and c) the non-specifically bound III has some catalytic ability 
without a required rearrangement. While it is not possible to absolutely 
distinguish between these situations with the data available, (a) 
seems the more reasonable explanation. The situation described by (b) 
is thought to be the least likely to occur; and, while (c) is feasible, 
it is not as convenient as (a). The low enzymic activities of these 
analogs demonstrate the precise arrangement required at the active site 
for optimum catalytic ability. This would tend to discount the idea that 
non-specific binding of such a nature as to give an absorption maximum at 
a higher wavelength (and with a negative CD) could be similar enough to 
the active conformation to have catalytic ability. The process 
described by (b) would seem to be quite slow; therefore, (a) is the 
favored explanation. 
The addition of a-ketoglutarate to the amine form of apoGOT-III 
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resulted in the rapid formation of an enzyme-substrate complex absorbing 
at 323 mu which alowly transaminated to the aldehyde form absorbing 
at 370 my plus the amino acid product. That transamination is occurring 
is shown by the similar behavior of synthetic carboxymethyl-deosypyridox-
amine when bound to apoGOT. While the concentration of L-glutamate 
exceeded that of a-ketoglutarate in the experiment illustrated in 
Figure 13, transamination of the keto acid was not prevented. Further­
more, the equilibrium lies strongly toward PLP and the amino acid in 
the native enzyme. Hence, while a-ketoglutarate is easily bound, it is 
not easily transaminated. 
In order to determine whether the low rate of transamination of 
the amino acid substrate (compared to that of the native enzyme) was 
caused by hindered binding of substrate or not, the Michaelis constant 
for L-glutamate was obtained for both apoGOT-III (Figure 14) and native 
a-GOT (Figure 7). Since a-ketoglutarate caused severe substrate inhi­
bition (see below) and because the initial velocities of apoGOT-III 
were so low, the oxaloacetate-L-glutamate assay system had to be 
employed. While V of apoGOT-III was one hundred times less than 
max 
Vfjjax for a-GOT, the for apoGOT-III was 5.7 times the Kg-j^ for a-GOT. 
Thus, L-glutamate shows some decrease in affinity for apoGOT-III com­
pared to native enzynœ. However, the low rates of transamination of 
apoGOT-III are also reflected by the effect of the analog on V ; hence, 
max 
either the analog is bound in an improper conformation at the active 
site, or the 5'-phosphate of PLP plays a mechanistic role during the 
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reaction (or both of these may be combined). 
In connection with conformational changes at the active site, the 
reactivity of apoGOT toward some substrates and inhibitors of native 
GOT was examined (Tables 2 and 3). Of interest are the observations: 
apoGOT-III showed more reactivity toward L-valine and more inhibition 
by glutarate, adipate, succinate, and a-ketoglutarate than did a-GOT; 
while the degree of inhibition by a-methyl-D) L-aspartate was about the 
same for both a-GOT and apoGOT-III. The reactivity toward L-valine 
demonstrates a decrease in specificity at the binding site of the 
hydrophobic chain by apo-GOT-III. The results for the inhibitors are 
interpreted to mean that III causes such distortion at the active site 
as to increase the affinity possessed by dicarboxylic acids. If the 
conclusions of Jenkins and D'Ari (1966b) regarding the binding of 
glutarate (ie. the second carboxyl group is bound at the protonated 
nitrogen of the aldimine linkage between the protein and the cofactor, 
and the dicarboxylic acid must undergo a conformational change after 
binding)are correct, then apoGOT-IIPs aldimine nitrogen may be placed 
so as to allow the dicarboxylic acids to bind without a conformational 
change (or with less required change). 
The complex formed by apoGOT-III and a-ketoglutarategave unexpected 
behavior at low pH. At pH 5.4, the CD of this complex exhibited a peak 
at about 450 mp (Figure 16) similar to that of the a-GOT-a-ketoglutarate 
complex (Figure 5), but of much lower magnitude. Furthermore, the 
negative CD at about 415 mm of apoGOT-III was enhanced with 
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a-ketoglutarate. The effect on the pK by a-ketoglutarate lends support 
to the idea that a carboxylate group is attached to (or in the immediate 
vicinity of) the imine nitrogen. On the basis of the negative CD at 
415 mu, it is apparent that a-ketoglutarate can interact with the non-
specifically bound III. Unlike the native enzyme, apoGOT-III's complex 
is unstable at pH 5.4 as shown by the absorption spectrum (Figure 15) 
compared with that of a-GOT (Figure 4). 
An exact interpretation of the positions occupied by the inter­
acting molecules at the active site of apoGOT-III is not possible 
without X-ray diffraction data, but it has been shown that analog III 
induces some distortion of GOT's active site. 
The reaction of apoGOT-IV with L-glutamate was quite rapid 
(<2 minutes) with respect to the appearance of the amine form absorbing 
at 325 my. However, while the aldimine form of apoGOT-IV (359 my) was 
decreasing, a species absorbing at 430 my was produced. The 430 my species 
was produced relatively quickly (maximum absorbance at 430 my occurred 
in about two minutes), but its subsequent conversion to the amine was 
slow. Thus, there exists two conformations of apoGOT-IV which absorb 
at 359 my; one which is capable of forming an amino acid Schiff base 
that is tautomerized to the ketimine easily, and the other conformation 
forming an amino acid Schiff base that is not as reactive. The amine 
form produced by either conformation does not react with a-ketoglutarate 
to produce a complex with a different absorption maximum, but it does not 
transaminate with a-ketoglutarate either. Hence, it may be possible that 
an abortive type of enzyme-a-ketoglutarate complex exists which absorbs 
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at 325 my similar to that of apoGOT-III. The other possibility is 
that the affinity of a-ketoglutarate is lowered because the conformation 
of the active site of apoGOT-IV amine is not favorable for keto acid 
binding. Whatever the reason, the lack of an oxygen atom between the 
5'-carbon and the phosphorus atom causes a large effect. 
ApoGOT-V gives a slow reaction with L-glutamate to produce apoGOT-Y 
amine which absorbs at 315 my. The methyl group attached to the phos­
phorous atom either hinders the binding of amino acid or inhibits the 
mechanistic role of the 5'-phosphate if the phosphate group plays such 
a role. Like apoGOT-III, the amine form of apoGOT-V shows the rapid 
formation of a complex with a-ketoglutarate by a very noticeable shift 
of the absorption maximum to 327 my. Subsequent transamination of this 
complex is very slow. 
With respect to the other 5'-analogs, apoGOT-VI gives a slower 
reaction with the amino acid to give the amine form which absorbs at 
317 my. The formation of a complex with a-ketoglutarate by the amine 
form of apoGOT-VI and the subsequent transamination of the complex 
was slower for this analog than for the others. Since compound V 
demonstrated a retarded behavior as a coenzyme, this effect of a large 
group (cyanoethyl) bonded to the S'-phosphate is not surprising. However, 
the slow activation of apoGOT-VI (Table 4) to an activity equivalent to 
that of PLP was unexpected. The activation was shown to be a first order 
process (Figure 27). Two explanations are possible: a) analog VI is 
bound initially in an inactive mode and is slowly rearranged to an active 
conformation, and b) analog VI is bound as the cyanoethyl ester and is 
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then slowly hydrolyzed to PLP while on the enzyme surface. Either 
process would give first order kinetics, but the second explains the 
small amount of absorption and CD at 430 mu exhibited at pH 5.4 (Figures 
25 and 26) and, hence, is the favored explanation. While the hydrolysis 
of the cyanoethyl group of VI is thought to occur on the surface of GOT, 
this phenomenon is not exhibited by two other pyridoxal phosphate 
enzymes (see page 71). 
ApoGOT-VIII was quite similar to apoGOT-III: rapid conversion of 
the aldimine (380 mu) to the amine form (320 my), a slower conversion to 
the amine form by the non-specifically bound cofactor, and a slow 
transamination with a-ketoglutarate. While a complex with a-ketoglutarate 
and the amine for with a different absorption maximum did not appear, 
such a complex could absorb at 320 my. 
In conclusion, the 5'-analogs examined in the study had a pronounced 
effect upon GOT's catalytic ability and upon the enzyme's spectral 
behavior. In particular, the formation of abortive complexes with 
a-ketoglutarate was more pronounced, and the proportion of non-
specifically bound cofactor was higher with these analogs than for the 
native enzyme. Furthermore, the pK of the iraine nitrogen was shown 
to depend upon the 5'-substituent. 
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Ring N-Analogs (IX and X) 
Binding characteristics 
Both of the pyridine ring nitrogen substituent analogs appeared 
to be bound firmly by apoGOT. N-methylpyridoxal phosphate (IX was 
bound more slowly than pyridoxal phosphate-N-oxide (X)» but with a 
higher degree of asymmetry associated with the binding. The aA/A value 
for IX at pH 8.3 was the same as that possessed by the native enzyme. 
IX did not exhibit non-specific binding of the type to give absorption 
above 400 mu. 
The binding of X to apoGOT at pH 8.3 gave a broad absorption band 
from 380 mu to 405 mu, a shoulder at 320 mu, and high absorption at 430 mu. 
Hence, several species of apoGOT-X are present. The number and nature 
of these species are not known. 
Since the 5'-substituent of both analogs is the normal phosphate 
ester, their spectra show a pH dependence in the range pH 5.0 to 8.3 
Ohishi, et (1968) reported absorption and CD maxima at 420 mu at 
pH 5.0 for GOT-X. 
Reaction with substrate 
With L-glutamate, apoGOT-IX reacted slowly (>20 minutes) to produce 
the amine form absorbing at 335 mu, the reverse reaction with a-keto-
glutarate was extreiœly slow. Only the two forms with absorption at 
377 mu and 335 mu were apparent. This behavior has two explanations: 
a) IX is bound in an unfavorable conformation for catalysis, or b) 
the methyl substituent prevents the pyridine ring nitrogen from playing 
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its mechanistic role as an "electron sink." 
ApoGOT-X reacted very rapidly to form the amine which absorbs at 
325 my. While the absorption from 380 mu to 405 mu was destroyed, a 
species absorbing at 425 mu reacted to form the amine at a slower rate. 
With a-ketoglutarate, the 325 mu absorption rapidly shifted to 320 mu 
which subsequently reduced as absorption at 425 mu increased. No 
absorption increase was noted in the 380 mu region. These spectral 
changes are very odd and do not explain the high catalytic activity 
(30% of the activity of native GOT) observed with this analog. While 
the transamination of amino acid seemed to proceed in a normal manner 
(although with several species of apoGOT-X present), the reaction of 
amine apoGOT-X with a-ketoglutarate did not produce an aldimine with 
absorption around 380 mu. Apparently, a Schiff base intermediate of X 
and amino acid (absorbing at 425 mu) is capable of hydrolyzing to 
release the amino acid product. 
The same explanations for IX's behavior may be advanced for X. 
However, in neither IX or X, is it known whether improper binding or 
Improper electron distribution in the cofactor is the correct explanation. 
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SUMMARY OF CONCLUSIONS 
1) Carboxymethyl-deoxypyrldoxal (III) is bound firmly to apoGOT. 
A non-specific type of binding with this cofactor was shown to occur 
at the active site of the enzyme. Ill affected both and î" 
the catalyzed transamination of L-glutamate. The conformation of the 
active site was shown to be distorted by the binding of III which in-
~ed the affinity of dicarboxylic acids for this site. While 
apoGOT-III did not show pH dependence of its absorption and CD spectra, 
its complex with a-ketoglutarate did. 
2) Deoxypyridoxaly1 phosphonic acid (IV) binds to apoGOT to form 
two different conformations at the active site. One of these conforma­
tions reacts with amino acid substrate to form the amine of apoGOT-IV, 
while the other produces an intermediate Schiff base which absorbs at 
430 mp. a-ketoglutarate does not alter the absorption spectrum of 
apoGOT-IV amine, but does not transaminate rapidly either. 
3) The methyl phosphonic acid of PLP (V) was bound to apoGOT at a 
slower rate than III or IV; furthermore, it was shown to be more easily 
dissociated from the protein than either III or IV. With substrate added, 
apoGOT gave a slow reaction with L-glutamate and a notable complex of 
the amine form with a-ketoglutarate. 
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4) The cyanoethyl ester of PLP (VI) was bound slowly to apoGOT 
and demonstrated a very slow reactivity with substrates which was 
caused by the steric hindrance imposed by the bulky cyanoethyl group. 
The slow activation of apoGOT-VI is thought to be due to PLP formed 
by the hydrolysis of VI on the enzyme surface. 
5) Deoxypyridoxal (VIII) was bound to apoGOT with a lower asymmetry 
associated with the binding site than the other 5'-analogs. In addition, 
VIII shows a higher degree of non-specific binding. A complex of 
a-ketoglutarate and the amine form of apoGOT-VIII was not observed 
spectrophotometrically, although the transamination of a-ketoglutarate 
was very low. 
6) The 5'-analogs all showed more of a tendency toward non­
specific binding and a higher degree of keto acid abortive complex 
formation than the native enzyme did. 
7) the pK of the aldimine formed between cofactor and protein 
was shown to be dependent upon the 5'-substituent. 
8) The pyridine ring nitrogen substituents, N-methyl PLP (IX) 
and PLP-N-oxide (X), were bound to apoGOT and possessed pH dependent 
absorption and CD spectra. IX exhibited very low catalytic ability 
while X had 30% of the activity of native GOT. It is suggested that the 
difference in activity between IX and X may be caused either by improper 
binding or by the substituent's effect upon the ring nitrogen. It is not 
known which of these is the correct explanation. 
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